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ABS.TRACT 
Goldberg, Ronald Lee. Ph.D., University of Rhode Island, 1980. 
A mechanism of action of gold in rheumatoid arthritis: a bio-
chemical and morphological investigation of the direct effect 
of gold sodium thiomalate (GST) on human synovial cells in cul-
ture. Major Professor: Dr. George C. Fuller. 
Gold sodium thiomalate (GST) effects on cultured rheuma-
toid synovial cells were used as a model to investigate a mech-
anism which can explain clinical benefits gained by patients 
from gold therapy. Synovial tissue obtained from patients with 
rheumatoid arthritis who were undergoing reconstructive joint 
surgery was used to obtain explant culture of synovial cells. 
The experiments described were performed on growing monolayer 
cultures during the second to fifth passages. Synovial cells 
were exposed to GST at pharmacologically relevant concentra-
tions (10-100 uM). Vacuoles were found by phase contrast micro-
scopy in synovial cells in culture after 2 days of exposure to 
100 uM GST. The vacuoles,aurosomes, were found to contain 
electron dense material by electron microscopy that contained 
gold as identified by X-ray probe analysis. The structure of 
the aurosomes, electron dense lamellae structures in membrane 
bound vesicles, was found to be similar to those found in 
synovial tissue of patients with rheumatoid arthritis who had 
received gold therapy. The time course for gold accumulation 
in the cell layer paralleled with aurosome formation and the 
degree of inhibition of [ 3H]thymidine incorporation into DNA. 
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DNA synthesis, DNA content and cell number were decreased in 
a dose dependent manner after synovial cells were exposed to 
GST containing medium. The synthesis of medium proteins per 
flask by synovial cells was decreased in a dose dependent 
manner with collagen decreased to a greater extent. The per-
centage of collagen to total protein synthesized by synovial 
cells was decreased in a dose dependent manner. A biphasic 
response of an increase followed by a decrease of proteins 
synthesized per cell or per DNA unit was found due to GST ex-
posure. The increase in collagen protein per cell was found 
to be predominantly type I collagen. The percentage of type 
III collagen decreased due to synovial cells exposure to GST 
containing medium. Removal of GST from the medium resulted 
in recovery of biochemical parameters at low concentrations 
and a partial recovery at high concentration. Neither auro-
somes nor gold could be completely removed from synovial cells 
after medium changes and subculturing. An important thera-
peutic mechanism of action of gold in the treatment of pa-
tients with rheumatoid arthritis may be by directly inhibit-
ing synovial cells proliferation and altering protein syn-
thesis by synovial cells to a nonconducive matrix for pannus 
expansion. 
iii 
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I. INTRODUCTION 
Gold has been used for half a century to treat rheumatoid 
arthritis (RA} . Although the rationale for the introduction 
of gold compounds into therapeutics was based upon gold's bac~ 
tericidal property, RA has not been established to oe bacteri-
al in origin and gold does· not eradicate tfie bacterial infec-
tions in laboratory· animal models· of RA. Therefore, the in--
troduction of gold salts in treating RA is not now believed 
to be related to the original proposed mechaniS1ll of action 
of the agent. The efficacy· of gold therapy, chrysotherapy, 
has firmly been established in several double Blind studies. 
Theories dealing with the mechanism of action of gold are 
concerned with the interaction of gold with ·inflanunatory 
and immunological process-es-. No single theory can fully ex-
plain the clinical benefits RA patients derive from chryso-
therapy. 
Animal and cell culture models are used to study RA, 
but no single model can reflect the· complex disease of human 
RA. Because rheumatoid hyperplastic synovium, the pannus, 
invades· the surrounding connective tis-sue of the joint, 
gold's therapeutic effect may be related to a direct effect 
on the proliferating synovial cells. To tes·t this hypothesis, 
gold sodium thiomalate CGSTl at pharmacologically relevant 
concentrations· was added to the medium of synovial cells de-
rived from RA patients' synovial tissue, pannus, explants. 
2 
In this model, the synovial cells developed an analogous gold 
induced morphological change in vitro as was found in gold 
treated patients' synovial cells in vivo. The biochemical 
changes in gold-exposed synovial cells reported in this dis-
sertation may be important factors in the efficacy of gold in 
RA. 
A better understanding of the mechanism of action of a 
proven therapeutic drug will hopefully lead to the develop-
ment of a more efficacious, less toxic drug and a better 
understanding of the pathophysiology of rheumatoid arthritis. 
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II. LITERATURE SURVEY 
A. Rheumatoid Arthritis 
Among the diseases which cause chronic loss of func-
tional capabilities, arthritis and rheumatism are second only 
to cardiovascular diseases. "There is no othe·r group of di-
seases which causes so much suffering by so many for so long 
(Hollander, 1972) ." Approximately 5% of the total world pop-
ulation are affected and over 11 million Americans suffer 
from rheumatism and arthritis. Of these, osteoarthritis, 
degenerative joint disease, is the most common, but rheuma-
t~id arthritis (RA) is a greater problem with regard to 
severity and prolonged disability. Arthritis rarely kills; 
it is the life-long crippling rather than mortality that is 
the problem. 
1. Etiology of rheumatoid ·arthr.itis. 
The etiology of rheumatoid arthritis (RA) is still 
an enigma. Theories· for the origin of RA include infections, 
metabolic, nutrition, endocrine, autoimmune, trauma, ~environ­
mental, psychosomatic, genetic and a multifactoral of the 
above. According to Person and Sharp (1977), RA is a con~ 
venient designation to describe a clinically, serologically 
and etiologically heterogenous group of conditions. 
An analogous disease to human RA can be produced in ani-
mals by bacterial infection (Cecil et· al., 1939 and Timoney 
4 
and Berman, 1970). Similarly, mycoplasma, viruses and anti-
genic proteins can elicit inflammatory joint reactions 
(Consden et al., 1971; Cooke et al., 1974; Currey, 1970; 
Stuart et al., 1979 and Chambers and Bywaters, 1963). The 
infective agent (or the antigen) cannot always be cultured 
or found in the inflamed joint (Cole et al., 1973 and Person 
et al., 1973). Therefore, the initial trigger for RA need 
not be associated with the joint or the patient during the 
active disease process. The transfer of homologous nodules 
in laboratory animals does not cause a rheumatoid-like ar-
thritis. Even the transfer of serum or synovial fluid from 
RA patients to non-RA patients does not transmit the rheu-
matic disease (Harris and Vaughan, 1961) . 
There may be a . genetic predisposition to RA (Wasmuth 
et al., 1972). Unlike ankylosing spondylitis which is linked 
with the HLA-B-27A loci (Pasternack and Tulikaine, 1977), 
there is only a modest increased frequency of HLA-Dw3 and 
HLA-Dw4 loci (McMichael et al., 1977) found associated with 
RA patients (4 times more often than non-RA controls). The 
classic rheumatoid factor (RF) , IgM antibodies directed 
against IgG, is associated with 70-80% of RA patients but 
is not specific to RA. Patients with bacterial endocarditis 
and systemic lupus erythomatosis often are RF positive as is 
5% of the normal healthy population (Bartfeld, 1969 and 
Williams, 1974). These again point to RA as a heterogenous 
disease with possible different origins and a multifactoral 
etiology with a common manifestation of RA. 
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2. Pathogenesis of rheumatoid arthritis. 
Although the etiology of RA is unknown, much is known 
about the pathogenesis of this disease. The defense mecha-
nisms of the body, both humeral and cellular immunity, play 
important roles in the pathogenesis of RA. An initial syno-
vi tis (of unknown origin) evokes an immunological sequel of 
events that result in antibodies to autoantigens. Antibodies 
directed against (self-components) nucleic acids, collagens, 
fibrin and lymphocytes have been found in the serum and sy-
novial fluid of RA patients (Osgood, 1976 and Williams, 1974). 
The primary of fending agent is thought to be antibodies di-
rected against the Fe portion of the Y-globulin (IgG) (Natvig 
and Munths, 1975). Seropositive RA patients are defined as 
patients with immunoglobulin M (IgM) antibodies, directed 
against IgG. These antibodies have been identified as the 
classical rheumatoid factor. Both seropositive and sero-
negative patients have a rheumatoid factor consisting of 
IgG anti-IgG. When these autoantibodies reach a critical 
titer, they form immune complexes in the synovial fluid and, 
to a lesser extent, in the synovial tissues (Natvig and 
Melblye, 1979). Normal synovial fluid usually has the same 
amount of compliment (C) activity as found in serum, but 
rheumatoid joint fluid has a depleted level of C activity 
due to activation of both the classical and alternate C 
pathways by the immune complexes. High concentrations of 
the chemotactic factors for granulocytes (C3a, CSa and C567) 
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are formed in the activation of the C pathway (Ward and 
Zvaifler, 1971). A large number of neutrophils polymorpho-
nuclear cells (PMNs) , infiltrate the inflamed rheumatoid 
joint synovium. However, most are found in the synovial 
fluid where the neutrophils phagocytize large amounts of C3 
and immune complexes. Inflammatory mediators and hydrolytic 
enzymes are released from the phagocytosing neutrophils 
(regurgitation during feeding or cell death) that perpetuate 
the inflammation and subsequently degrade the cartilage con-
nective tissues. Attracted mononuclear cells, lymphocytes 
and macrophages, infiltrate the edematous, hypertrophied 
and hyperplastic synovial tissue. Lymphocytes proliferate 
in synovial tissue and sometimes form germinal centers 
around blood vessels, as in a lymph node, where B-lympho-
cytes become plasma cells to produce more antibodies (e.g., 
rheumatoid factors) that perpetuate the disease. Most of 
the lymphocytes in the synovium are T-lymphocytes (75%). 
The cellular immunity, delayed type hypersensitivity, 
is very important in the pathogenesis of RA (Natvig and 
Mellbye, 1979). The subpopulation of T-cells and their 
functions include: k-cells, killer cells which are cyto-
toxic to other cells by direct contact; h-cells, helper 
cells that cooperate with B cells in antibody production, 
and s-cells, suppressor cells that modulate the B cell anti-
body production. A lack of suppression by the s-cells to 
allow the production of forbidden clone(s) appear to be an 
import~nt factor in the development of the RA lesion 
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(Tannenbaum and Shur, 1974). Lymphocytes elaborate many types 
of lymphokines. Factors like macrophage inhibitory factor 
(MIF) keeps macrophages in the inflamed synovium. Lymphokines 
can stimulate macropages to release factors which cause the 
lymphocytes to proliferate. Lymphokines injected into a rab-
bit joint causes a rheumatoid-like arthritis, and lymphokines 
or mononuclear cell factors can stimulate synovial cells to 
proliferate and produce collagen in culture (Stastny et al., 
1975). Inflammatory mediators and modulators including 
bradykinins, histamine, seratonin, SRS-A, platelet factors 
and prostaglandins interact synergistically to perpetuate 
the inflammation. Positive feedback loops with immunologi-
cal and inflammatory cells and immunological and inflmmatory 
factors perpetuate the disease resulting in swelling and 
pain (Zvaifer, 1970 and 1973). Eventually, the hyperplastic 
synovium invades other connective tissue compounds (cartilage, 
bone or ligaments) and is then called a pannus (Harris, 1974, 
1976 and Harris et al., 1972). At the edge of the pannus, 
proteolytic enzymes including mammalian collagenase have 
been identified by immunofluorescence (Wooley et al., 1975 
and 1977). Irreversible damage occurs when the pannus en-
zymes digest the structural protein collagen. Pannus growth 
may be stopped by either blocking the stimulatory factors 
that promote the growth of the granulation type tissue, pre-
venting the formation of the granulation extracellular matrix, 
blocking enzyme release at the edge of the pannus or inhibit-
ing synovial cell division. Preventing the irreversible 
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joint damage due to the pannus is important because eventual-
ly the damage could lead to loss of function of the joint. 
3: Pharmacoloqic·a1 Man·ageinent o"f rheuma tbid" ·arthritis. 
At present no drugs are known to adequately control 
chronic inflammatory diseases like RA in all clinical situa-· 
tions. Drugs used today only suppress the disease. Thera~ 
peutic management of RA is to reduce inflammation and pain, 
with attempts to maintain function and prevent deformities. 
In treating the RA patient, drug therapy is only one compo-· 
nent of the management. Physical therapy, nutrition and 
psychology for chronic, possioly disabling, disease are also 
important. 
a. First line drugs 
Nonsteroidal anti-inflanunatory agent (NS"AIAJ are 
the first line drugs us·ed to treat RA. The NSAIA were 
thought to work by uncoupling oxidative ·phosphorylation 
(Whitehouse, 1963); h_owever, -more specific drugs for uncoupl-
ing oxidative phosphorylation \e.g., dinitropheriolJ. are not 
anti-inflanunatory. The present theory most widely accepted 
for NSAIA mechanisms of action is inhibition of prostaglandin 
synthesis (Vane, 1~71J . NSAIA drugs decrease the edema 
whicn causes the pain in morning stiffnes-s and are -mild anal~ 
gesics. Salicylate therapy, especially aspirin, is- used 
primarily because of low toxicity, efficacy and -mini-mal ex~ 
pense. If toxicity or lack of efficacy is found w-ith aspirin, 
other NSAIA such as indometh.acin are used. More potent drugs 
9 
are used alone or in conjunction with the NSAIA in the more 
severe cases of RA. 
b. Steroids 
When the inflammation of RA is not controlled 
by NSAIA, steroids are sometimes used. The mechanism of ac-
tion was thought to be via lysosomal membrane stabilization 
(Symons et al., 1961) but Ignarro (1972) presented evidence 
that this is an in vitro artifact. Anti-inflammatory steroids 
as well as hormonal steroids have been shown to bind to a 
cytoplasm receptor. The steroid-receptor "active complex" 
is transported to the nucleus resulting in the repression 
and activation of transcription of mRNAs from DNA (Haynes 
and Larner, 1975). One of the pharmacological properties of 
hormonal and anti-inflanunatory steroids is selective gene 
expression for protein synthesis. Inhibition of lymphocyte 
proliferation and lymphokine production (Weston et al., 1973 
and Kayashima et al., 1978) and inhibition of prostaglandin 
release (Lewis and Piper, 1975) by blocking the phospholipase 
enzyme have also been proposed to explain the action of anti-
inflammatory steroids. A long-term hazard of systemic corti-
costeroids, Cushing's disease, makes steroid therapy a con-
troversial form of treatment (Hess and Goldman, 1972 and 
Dayer et al., 1976). The intraarticular injection of ster-' 
oids are useful and decrease the systemic problems associ-
ated with the systemic use of this drug (Hess and Goldman, 
1972). Neither steroids nor NSAIA prevent the progression 
10 
of the pannus (Harvey, 1975), and therefore cannot prevent 
irreversible erosion causing the disabling consequence of 
the illness. 
c. Second line drugs 
Second line drugs are generally drugs used in 
chronic erosive disease which are characterized by a delay 
in onset of therapeutic action and a slow return of symptoms 
after termination of drug use. Hydroxychloroquine, gold 
salts and penicillamine all have severe side effects that need 
to be monitored, but there also is data to suggest these 
drugs inhibit the erosive consequence from the pannus (Co-
operative Clinic Conunittee ARA, 1973; Multicenter Trial Group, 
1973 and Mainland and Sutcliffe, 1962). The early signs of 
toxicity with gold salts and penicillamine are a pruritic 
dermatitis and a proteinuria which are reversible. Bone mar-
row suppression is the most dangerous side effect (Harvey, 
1972) and with hydroxycloriquine retinopathy leading to 
blindness can occur (Zvaifler, 1968 and Rubin et al., 1963). 
A sul5set of second line drugs include cytotoxic drugs. 
Cyclophosphamide and azathioprine were first used as anti-
cancer drugs and are carcinogens. It is thought that these 
drugs are immunosuppressive and prevent pannus progression 
(Urowitz, 1974). The use of these drugs is restricted to 
only the most resistent cases ("Cooperative Clinic Committee 
ARA, 1970). 
11 
B. Animal Models for Rheumatoid Arthritis 
1. Adj uvant rat -model. 
No one experimental model has all the characteris~ 
tics of human RA. The animal model -most commonly used is 
the rodent adjuvant arthritis [Stoerck et al., lg54}. This 
is a polyarthritis that can be induced by a single i.p. in-
jection of killed mycobacteria or tuberculin [Currey, 1970). 
The antigen responsible is the peptidoglycan of max D (Adam 
et al., 1972) from the bacteria cell wall. The suppressor 
T-lymphocytes play a major role in the development of the 
disease (Kayashima et al., 1978). Even though many similar-
ities exist between this model and human RA, rheumatoid 
nodules and rheumatoid factor are not present ("Pearson, 1972) . 
2. Antigen rabbit model. 
Another model is the antigen-·induced arthritis in 
rabbits. The rabbit is immunized with a protein antigen, 
e.g. fibrin (Dumonde and Glyn, 1962). Several weeks later 
the antigen is injected into the joint. A monoarticular 
arthritis develops with neutrophils and mononuclear infil-
trates. Immunoglobulin synthesis by lymphocytes in the sy-
novial tissue are directed against the challenge antigen 
(Cooke and Jasin, 1972 and Cooke and Richer, 1974). The 
histology of the synovial tissue in this model is very sim-
ilar to the pannus, though in human RA there is usually a 
polyarthritis. 
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3. Collagen induced arthritis. 
Recently, a type of rodent arthritis was found to 
be caused by injection of collagen. Native but not denatured 
type II collagen injected subcutaneously caused a polyarth-
ritis in rats (Stuart et al., 1979a, b). A similar model of 
collagen induced arthritis was also induced in rabbits 
(Steffen et al., 1979). Collagen induced arthritis might 
have clinical relevance. Andriopulous et al. (1976) found 
antibodies against type II collagen in the sera of patients 
with RA. The antibody titers were highest against denatured 
rather than native types II and I collagen. It is unlikely 
that collagen is the unknown trigger antigen in RA. Rather 
the breakdown of cartilage by the pannus releasing type II 
collagen acts as an antigen which perpetuate the inflamma-
tion. 
Gardner (1960) reviewed the experimental models for RA 
and classified them into five groups, infective, chemical, 
immunological, endocrine and physical. His conclusion that 
because of the lack of resemblance to human RA, that future 
investigations should be conducted with human tissue is still 
true two decades later with the newer animal models. 
c. Human Synovial Tissue and Cells in Culture 
1. Tissue. 
The diathroid (free moving) joint has two periosteal 
bones covered at their articular end with hyaline cartilage, 
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held together by fibrous ligaments, which form a joint cap-
sule. The inner lining of the joint capsule has a one to 
three cell layer thick membrane called the synovial membrane. 
Synovial fluid is a viscous translucent yellow-colored li-
quid within the diathroid joint. The composition of synovial 
fluid is an ultrafiltrate of plasma plus protein, glyco-
saminoglycans and a hyaluronic acid secreted by the synovial 
cells. The synovial cells also keep the synovial fluid 
clear by phagocytosis of particulate matter and invading 
organisms. 
2. Cells and culture models. 
Three cell types have been characterized in the 
synovial membrane (Barland et al., 1962). Type A cells are 
phagocytic macrophage like cells with many vacuo1.es. Type 
B cells a ~ e fibroblast-like cells with abundant rough endo-
plasmic reticulum. Type C cells are either precursors or 
an intermediate between type A and B cells. 
Two techniques are currently used for initiating sy-
novial cell cultures. One is the enzymatic release adhesion 
method; the other is the explant method. Both methods 
result in heterogeneous cell populations in culture (Marsh 
et al., 1978). 
a. Enzymatic release-adhesion 
The enzyme release adhesion method results in 
primary cultures of cells which are dissociated from the 
tissue with collagenase and trypsin. The cells are inocu-
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lated into the medium in a cell culture f lask. After an 
hour the medium is removed and the cells attached to the 
flask are used for the cultures. These cell s produce rela-
tively large quantities of collagenase and prostaglandins 
(Dayer et al., 1976). Some adherent synovial cells (ASC) 
assume a stellate morphology in culture but do not possess 
the immunoglobulin (EA) or compliment (EAC) r .eceptors 
(Dayer and Krane, 1978). 
b. Explant 
The explant culture method first described by 
Vaubel (1933a, b) produces heterogenous populations of cells 
that grow out on the culture plate from a · small minced 
piece of synovial tissue. These cells produce mucopoly-
saccaride, hyaluronic acid and collagen (Castor, 1957 and 
1970) • These observations are compatible with the conclu-
sion that for the study of enzymatic activity, the protea-
lytic release-adherent cell culture model would be used, 
and that for the synthesis of connective tissue components, 
the explant method would be a preferred cell culture model. 
Frazer et al. (1979) described a type 1 and 2 pattern 
of changes with synovial cells derived from primary culture 
explants. The type 1 response consists of increased vacu-
oles, increased degradation enzymes and decreased hyaluronic 
acid obtained with sucrose (8mM), adenosine (0.4mM) and 
serum (50% v/v). The type 2 response consists of increased 
hyaluronic acid synthesis and dendrite formation obtained 
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by increasing intracellular c-AMP (cholera toxin and dbc-AMP) 
and carrageenin (Clarris et al., 1979). 
Glen-Bott (1972) examined the ultrastructure of synovial 
cells in situ and in culture. Because of the substantial dif-
ference, he concluded that culture cells do not reflect their 
function in vivo. There are certain functions that synovial 
cells do retain in culture as stated above, but still one 
should be cautious in the interpretation. 
By definition, synovial cells are cells derived from sy-
novial tissue. At present, no biochemical, morphological, 
or cell surface markers are used to define a culture as sy-
novial cells. The relationship of synovial cells in culture 
may be related to -the synovial cell ih situ as follows. The 
explant culture method may select for the type B synoviocytes 
because in culture these cells produce structural proteins 
such as collagen and carbohydrates such as hyaluronic acid. 
These cells also have a fibroblast-like morphology with 
abundant rough endoplasmic reticulum and golgi apparatus. The 
adherent culture method ·may select for the type A synovio..-
cyte because in culture these cells produce proteolytic en-
zymes like collagenase, and have abundant vacuoles typical 
for a phagocytic cell. The type 1 and 2 response in culture 
may be the commitment or differentiation of a type C cell 
to either an A or B synoviocyte which is thought to occur 
in vivo. 
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c. Rheumatoid disease in culture: 
The human synovial cell culture model has been 
used for over forty years to study and better understand rheu-
matoid arthritis. It is controversial, however, whether 
rheumatoid disease can be brought into culture. The compari-
son of normal versus rheumatoid-derived synovial cell lines 
results in conflicting results. No morphological difference 
was found in the rheumatoid synovial cells by Castor and 
Dorstewitz (1966), Waynne-Roberts and Castor (1972) and 
Ghose et al. (1975). An increase in multinucleated cells, 
cytoplasm granulation and media particles in RA synovial 
cell was reported by Bartfeld (1965), Goldfisher et al., (1968) 
Smith and Hamerman (1969) and Marsh et al. (1974 and 1977). 
Castor and Dorstewitz (1966), Smith and Hamerman (1969) and 
Marsh et al. (1974) reported slower doubling and shorter 
life span in culture for rheumatoid cells, whereas, Ghose 
et al. (_1975) found no difference. Castor (1973) found an 
--
increase in low molecular weight hyaluronic acid in the me-
dium of the rheumatoid synovial cel~ls relative to the non-
rheumatoid. This particular change is characteristic of 
the synovial fluid in RA. Vuorio (1977) confirmed the above 
changes in rheumatoid and nonrheumatoid synovial cells and 
also found a 75,000 dalton membrane protein only in rheuma-
toid synovial cell membranes. Smith (1970) reported a growth 
inhibitor (GI) in rheumatoid synovial cells. Possibly the 
growth inhibitor is reponsible for slower doubling times 
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of rheumatoid cultures. The heterogenity of rheumatoid di-
sease and the heterogenity of synovial cells make it diffi-
cult, so far, to have a parameter as an indicator for RA 
synovial cells. 
3. Peptide modulators effects in culture. 
The addition of endogenous peptides can modulate 
cell metabolism. Castor (1971) first described connective 
tissue activating peptide (CTAP) which was derived from leu-
kocytes. CTAP increased glucose uptake, lactic acid forma-
tion and hyper-production of low molecular weight hyaluronic 
acid. Castor et al. (1979) have described at least four dif-
- -
ferent types of CTAP: CTAP-I from lymphoid tissue, CTAP-II 
from a tumor cell line, CTAP-III from platelets, and CTAP-ex 
from neutrophils. 
Korn et al. (1980) found that mononuclear supernates 
(MCS) stimulated PGE 2 production and suppressed proliferation 
of human dermal fibroblasts. Wahl et al. (1978) with fibro-
blasts and Parrott et al. (1980) with synovial cells found 
MCS to stimulate proliferation and collagen synthesis. 
Jimenez et al. (1979) found MCS inhibited collagen synthe-
sis .. of fibroblasts. There are (pr.esumably) both inhibitors 
and activators in the MCS~ Inhibition or activation depends 
upon the preparation and the cells used. 
Burke and Ross (1977), Kohler and Lipton (1974) and 
Castor et al. (1979) found platelet factors to stimulated 
synovial cells and fibroblast proliferation. Collagen 
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synthesis was increased with platelet factors (Burke and 
Ross, 19 77) • 
One of the problems of bringing the rheumatoid disease 
into culture is the possibility that "normal" synovial cells 
placed into an environment conducive to proliferation may be-
have like rheumatoid cells. Factors (peptides) found in 
fetal calf serum may have many of the stimulatory and inhibi-
tory factors described above. The only differences in rheu-
matoid and nonrheumatoid cell lines may be the enrichment of 
a certain cell population in the cultures derived from RA 
patients. 
4. Effect of Antirheumatic drugs on cells in culture. 
The addition of antirheumatic drugs to cells in cul-
ture is a means of studying changes that may be related to 
their mechanisms of action. Castor (1972) found the effect 
of CTAP was blocked by corticoid, NSAIA and adrenergic block-
ing drugs (Castor, 1975). Colchicine, choroquine and gold 
sodium thiomalate were ineffective. Rheumatoid cells were 
reported to be less responsive than normal synovial cells to 
hydrocortisone stimulation of proliferation and inhibition 
of hyaluronic acid synthesis (Castor and Drowitz, 1966). 
Ponec et al. (1979) reported that glucocortico~teroids de-
creased collagen synthesis without effecting hydroxylation. 
Bayer et al. (1979) reported that indomethacin reversibly 
blocked cell proliferation in the G1 phase. Schorn et al. 
(1979) reported that penicillamine suppresses collagen 
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biosynthesis which may be related to the patient's clinical 
improvement of rheumatoid arthritis. The effects of drugs 
in culture or in vitro are a good indication of mechanism 
but are not proof (i.e., membrane stabilization with ster-
oids (Ignarro, 1972)). 
D. Role of Collagen 
1. Structure and synthesis. 
Collagens are the structural proteins of the extra-
cellular matrix. They consist of three polypeptides, a chains, 
circa 1000 amino acid long twisted into a helix, l.5nMX300nM. 
Only short sequences at each end are nonhelical. In the 
helical region the molecular formula is (gly-X-Y)333. When 
Y is proline, it is usually hydroxylated. The hydroxylation 
of proline is important for a stable helix at body tempera-
ture. Imino acids account for 25% of the residues in colla-
gen, limiting the rotation of the polypeptide backbone 
(Ramachandran and Ramakrishnan, 1976, and Kivirikko and 
Risteli, 1976). 
Collagens are first synthesized as 40% larger procolla-
gens a chains. After the message is transcribed from the 
DNA, the rnRNA is translated on polyribosomes. While the 
nascent chain is being elongated into the rough endoplasmic 
reticulum cisterne, some proline and lysine residues are 
hydroxylated by prolyl and lysl hydroxylases. Some hydroxy-
lation also occurs as the procollagen is transported to the 
smooth endoplasmic reticulum and the golgi apparatus. Sites 
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of glycosylation are on hydroxylated lysine residues. The 
carboxy terminal procollagen extensions have cystein resi-
dues that hold three procollagen together for helix forma-
tion (Byers et al., 1975). Helix formation is necessary 
for rapid secretion of functional protein. Some of the pro-
collagen produced may be aggregated and degraded intra-
cell ularly (Prockop et al., 1979, Brenkowski et al., 1978). 
Once the procollagens are secreted, extracellular-
post-translational modifications take place (Goldberg et al., 
1975). The procollagen peptides are cleaved at both the 
amine and carboxy terminal by procollagen peptidases. The 
collagen aggregates are assembled in a quarterstagger model 
into fibrils. Lysl oxidase oxidatively deaminates lysine 
residues leaving aldehyde moieties which participate in 
intra- and intermolecular covalent crosslinks. Crosslink-
ing decreases the solubility, increases the tensile strength 
and decreases the susceptibility of collagen fibers to de-
gradation by collagenases (Prockop et al., 1979; Fuller and 
Mann, 1980 and Tanzer, 1976 and Bailey et al., 1974). 
2. Types of collagen. 
Five types of collagens requiring seven different 
genes have been described. Primary structure differences 
underlies differences in the extent of posttranslational 
modifications, and therefore, the function of each collagen 
type. Only recently are the relationship of collagen types 
to tissue differentiation and disease processes being eluci-
dated (Eyre, 1980; Fuller and Mann, 1980, and Lapiere and 
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Nusgens, 1976). 
Collagen has a nonconventional protein nomenclature. The 
Greek letter a , 8 and y mean monomer, dimer and trimer. The 
tertiary structure of the collagen molecule is a trimer but 
separation of denatured collagen results in a , s , y and 
higher molecular weight forms due to lysine and histadine 
derived covalent intra- (holds together the tertiary struc-
ture) and inter- (holds together the quatenary structure) 
crosslinks (Tanzer, 1976). The arabic numbers (1,2) follow-
ing the Greek letter a indicate the order of the a chain 
elution from a carboxymethyl cellulose column for that type 
of collagen. The subscript arabic number is the number of 
chains found in the collagen molecule. The Roman numer-
al (I, II ••• ) indicates the collagen type. 
Type I collagen, [ a l(I)] 2a 2 is found ubiquitously and 
forms thick fibrils. Only a few of the hydroxylysines are 
glycosylated. Bone, tendon, dentin, ligaments and scars are 
predominantly type I collagen (Prockop et al., 1979). 
Type III collagen, [al(III) J 3 is usually associated 
with type I collagen and is found in greatest abundance in 
more elastic tissues such as lung, blood vessels, fetal skin 
and granulation tissue. There is a shift from a type III 
to a type I collagen predominance with the maturation of 
skin from fetal to adult as well as in the transformation 
from granulation tissue to scar tissue (Epstein, 1974, 
Epstein and Munderlok, 1975, and Bailey et al., 1973 and 1975). 
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Fine reticulin fibers contain type III collagen but this 
collagen is not the basis for the histological silver stain-
ing (Norwalk et al., 1974 and Timple et al., 1977). Type 
III collagen has a low hydroxylysine and carbohydrate content 
but a high hydroxyproline content. The three a l(III) chains 
are held together by disulfide bonds at the end of the heli-
cal region of the carboxy terminal (Chung and Miller, 1974). 
Type II collagen is found in only a few tissues like 
cartilage, vitreous body and cornea which are soft tissues 
with a high water content. It consists of three a l(II) 
chains [ al(II)J 3 which are highly glyco~ylated and form 
thin fibrils (Miller, 1976). 
Type IV collagen [ a 1 (IV) ] 3 is a basement membrane col-
lagen. This collagen has a high hydroxylsine content nearly 
completely glycosylated, a low alanine content and retains 
much of the procollagen nonhelical extension pieces (Jaffe 
et al., 1976 and Eyre, 1970). Metastatic tumors produce 
collagenases specific for this collagen (Liotta et al., 1977 
and 1979). 
A type V collagen has recently been characterized 
(Burgeson et al., 1976). The molecular composition may be 
a A [ (aB)] 2 or (a A) 3 and (a B) 3 (Rhodes and Miller, 1978; 
Deyl et al., 1979). (Type V collagen has not to date been 
given the typical collagen nomenclature.) This collagen is 
found ubiquitously but in small amounts. Type V collagen is 
thought to be a cell surface collagen and may be important 
in cell migration (Eyre, 1980 and Stenn et al., 1979). 
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A type I trimer, [ a {I)J 3 has been reported in inflamed 
gingiva and is produced by cells in culture (Little et al., 
1977, Benya et al., 1977 and Narayanan et al., 1978). This 
may be an altered type I collagen or a different gene pro-
duct of a l(I) with similar composition (Eyre, 1980). 
3. Alteration of collagen types with disease. 
In some diseases there is an alteration of the 
tissue composition of collagen types. In some cases the al-
teration may be the primary lesion as in Ehlers-Danlos syn-
drome and osteogenic imperfecta or part of the pathogenesis 
as in cirrhosis and arteriosclerosis. In Ehlers Danlos syn-
drome type IV, there is a lack of type III collagen synthe-
sis (Pope et al., 1976). In osteogenesis imperfecta, skin 
cells synthesize a greater proportion of type III collagen 
(Penttinin et al., 1975 and Sykes et al., 1977). In mitral 
valve prolapse, ruptured chordae tendinae, Hammer et al., 
(1979) reported an absence of type III and type V collagens. 
In diabetes melatus, an increase in the relative syn-
thesis of type III collagen in skin has been reported (Kern 
et al., 1979). In liver cirrhosis, there is an increase in 
both type I and III with type I increasing more than type 
III collagen (Rojkind and Martinez-Palomo, 1976 and Seyes 
et al., 1977). Similarly, in arteriosclerosis there is an 
increase in aorta collagen synthesis with type I collagen 
predominating (Fisher et al., 1980 and Mccullagh and Balian, 
1975). With both cirrhosis (Rojkind and Martinez-Palomo, 
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1976) and arteriosclerosis (Burke and Ross, 1979) ,as with 
granulation tissue (Gay et al., 1978 and Bailey et al:., 1973 
and 1975) there is first an increase in type III collagen 
followed by an increase in type I collagen. Gay et al. 
(1978) proposed that the mesenchymal cells predominate early 
in wound healing and produce predominantly type III collagen, 
while later mature fibroblasts predominate and synthesize 
more type I collagen. 
4. Synovial collagen. 
The data implicating a change in the collagen heter-
ogeneity in the rheumatoid synovium are conflicting. Weiss 
et al. (1975) found a higher proportion of type III collagen 
relative to type I collagen in the rheumatoid versus the 
nonrheumatoid synovium. Their results were criticized by 
Eyre and Muir (1975a) in that less than 20% of the total 
normal synovium collagen was pepsin-acetic acid extracted. 
Using a cyanogen bromide extraction, which extracts more 
than 80% of the collagen, Eyre and Muir (1975b) found the 
ratios of type I/III collagen to be similar in rheumatoid 
and nonrheumatoid synovial tissue. Both groups agreed the 
rheumatoid collagen was more susceptible to pepsin extrac-
tion. Brown et al. (1979) extracted type V collagen from 
synovial tissue. This collagen represented less than 2% 
of the total collagen. Normal and rheumatoid synovium 
have relatively similar amounts. 
Subcultured synovial cells in culture produce a simi-
lar ratio of type I/III collagen (Parrott et al., 1980 and 
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Vuorio, 1979). The rheumatoid primary cell cultures pro-
duced a greater percentage of type III collagen than the 
subcultured cells; also, the rheumatoid cell lines main-
tained a greater propensity for synthesis of type III colla-
gen than nonrheumatoid cell lines (Parrott et al., 1980). 
Again the rheumatoid disease is heterogenous, as are patients. 
The factors influencing the types of collagen could be re-
lative to the amount of different cells brought into cul-
ture. The age of the patient and the stage of the disease 
in the synovium at the time of the operation, may also in-
fluence the cell culture population. 
E. Gold in Rheumatoid Arthritis 
1. Efficacy and Toxicity 
Forestier (1929) reported beneficial effects of 
gold therapy in RA patients. Numerous reports followed con~ ­
firming the efficacy of gold in RA but most were not con-
trolled or double blind studies. Extensive double blind 
studies were reported by the Research Subcommittee of the 
Empire Rheumatism Council of Great Britain (1960, 1961) and 
the Cooperative Clinics Committee of the American Rheuma-
tism Association (1973). Both groups found that gold 
treated patients had stronger grips, decreased erythrocyte 
sedimentation rates (ESR) and fewer involved joints. The 
cooperative clinic did not find radiological improvement 
but a longer (2 year) double blind study (Sigler et al., 
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1974) reported significant radiological improvement with re-
gard to the progression of bone and cartilage destruction. 
In some patients the disease process was arrested. The per-
centage of patients benefiting from chrysotherapy is 40-75% 
depending upon the study (Freyberg, 1972). 
The first sign of gold toxicity is pruritis followed by 
dermatitis. · More dangerous common side effects are blood 
dyscrasias-thrombocytopenia, leukopenia agranulocytosis and 
aplastic anemia. Patients receiving chrysotherapy may de-
velop a proteinuria which on occasion will warrant discon-
tinuance of gold treatments. There is no correlation be-
tween toxicity and therapeutics (Harvey, 1975 and Freyberg, 
1972). 
2. Pharmacokinetics 
a. Whole body-blood and tissue 
Gold sodium thiomalate (GST) does not follow 
the classical drug pharmacokinetics. The gold moiety of 
the drug is not entirely eliminated (Gottlieb et al., 1972) 
and the blood levels do not correlate with therapeutics 
(Gerber et al., 1972) or toxicity (Mascarehas et al., 1972). 
The accumulation of gold in the tissues is a more important 
parameter than plasma levels (Smith et al., 1958). The peak 
plasma gold level, after an intramuscular injection of GST, 
is 4-6 hours. The half time of elimination is 2-3 weeks, 
though higher doses and longer duration of treatment will re-
duce the rate of elimination (Rubinstein and Dietz, 1973). 
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The thiomalate dissociates from gold sodium thiomalate and 
is eliminated more rapidly (Jellum et al., 1980). The mean 
blood gold levels attained in chrysotherapy with GST are be-
tween 2-5 ug Au/ml serum (Mascarehas et al., 1972 and Lorber 
et al. , 19 7 3) • 
There are reversible and irreversible deposits of gold 
in body tissues. The kidney, liver adrenals and reticule-
endothelial system have the highest concentrations (Go~tl~eb 
et al., 1972). The synovial tissue concentration of gold is 
20-50 ug/Au/g tissue. An inflamed synovium accumulates 
more gold than a noninflamed synovium (Grahame et al., 1974). 
b. Cellular-aurosomes. 
The gold deposited in the tissues is internal-
ized by the cells and sequestered in membrane-bound vesicles. 
The gold containing lysosomes have been named "aurosomes" by 
Oryschak and Ghadially (1974). Norton et al. (1968) de-
scribed membrane bound electron dense material in patients 
lysosomes after intra-articular injection of GST. They re-
ported similar electron dense material after thiomalic acid 
injection, though Ghadially (1978) has refuted these later 
findings with thiomalic -acid. The organic thio linked gold 
compounds, gold . sodium thiomalate (GST) and gold thioglucose 
(GSG) Au( I), form lamellar-like structures in the lysosomes 
and gold chloride, HAuC1 4 , Au(III), form aggregates in ly-
sosomes (Ghadially, 1979). Electron probe X-ray analysis 
has confirmed the electron dense material to be gold 
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(Ghadially et al., 1976). Stone and Galle (1969) observed 
gold deposits in kidney tubule mitochondria but further work 
is necessary to confirm this observation (Ghadially, 1978). 
Penney et al. (1976) quantitated the subcellular dis-
tribution of 195Au in Kupffer cells. The centrifuged frac-
tions corresponding to the nucleus and mitochondria contained 
the largest percentage of radioactivity. The interpretation 
of these findings is obscured because gold may alter the 
density of the organelle, and the aurosomes may become as 
large as a nucleus. Most of the gold in the cell is bound 
(Penney et al., 1975, and Lawson et al., 1977). The distri-
bution of gold binding to uncharacterized lysomal "macro-
molecules" was spread over a wide range. In the cytoplasm, 
"macromolecules" of 300,000, 40,000, 10,000 and 3,000 
. 
dalton bound gold (Lawson et al., 1977). 
3. Pharmacodynamic-mechanism of action. 
a. Protein interaction 
i. Albumin. - Heavy metals have a high affinity 
for sulfhydryl groups (Harvey, 1975). Ninety-five percent 
of the serum gold is bound to albumin (Mascarehas et al., 
1972). Gerber (1964) found that denatured albumin from the 
exposure to GST resembles a denatured albumin formed in the · 
presence of reagents that prevent sulfhydryl disulfide inter-
action. Albumin binding is most likely related to the phar-
macokinetics of gold. The pharmacodynamic binding or inter -
action of gold is still to be answered. 
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ii. Collagen. - Adam et al. (1965) found that 
after 8 weeks of gold thiosulfate (0.2 mg/Kg-rat/weekly) an 
in vivo staining of collagen occurred in which the collagen 
~ ~~
banding could be observed with the electron microscope. When 
the thiosulfate is cleaved, the gold moiety hardens the col-
lagen by forming new crosslinks as demonstrated by the swell-
ing of collagen fibrils and the contraction relaxation time 
(Adam and Kuhn, 1967). The solubility of collagen and the 
lathyritic effect of s-amino propionitrile were decreased 
due to gold thiosulfate (Adam et al., 1967). Bismuth, copper 
and mercury compounds also cause intra-vital crosslinks 
(Adam et al., 1968). The concentrations used in these stu-
dies are much higher than those used clinically but local 
concentrations of gold due to dying macrophages loaded with 
aurosomes may have a hardening effect on the collagen of the 
pannus. 
iii. Lysosomal enzymes. - The inhibition of 
lysosomal enzymes was proposed by Persellin and Ziff (1966) 
as a mechanism of action of gold sodium thiomalate. High 
concentrations of gold (mg/ml) were used to inhibit acid 
phosphatase, S-glucoronidase and malic dehydrogenase. Tis-
sue concentrations are 50 ug/g but the concentrations of 
gold in lysosomes, i.e. aurosomes, are much higher (Ghadially, 
1979), though most gold in the aurosomes is protein bound 
(Lawson, 1980). 
iv. Compliment. - Schultz et al. (1974) re-
ported the inactivation of Cl (compliment-classical pathway) 
with serum concentrations of gold. A lack of serum gold 
levels and therapeutic effect (Gerber et al., 1972) might 
indicate Cl and Cl esterase inactivation as a secondary 
rather than a primary mechanism of action of gold. 
b. Cell interaction. 
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i. Neutrophils. - Mowat (1978) found that neu-
trophil chemotaxis was inhibited in vitro by gold. Both 
non-RA patients and RA patients who gained clinical benefit 
from gold therapy, responders, have neutrophils that showed 
a gold induced, dose dependent, reduction in chemotaxis. 
Nonresponders did not exhibit a good dose dependent reduction 
compared to responders, suggesting that this assay may be 
a good means to screen for responders and nonresponders to 
chrysotherapy. More specific blockers of neutrophil chemo-
taxis have not been shown to be effective anti-rheumatic 
drugs. 
ii. Macrophages. - Jessop et al. (1973) re-
ported the phagocytic activity of neutrophils and macro-
phages was increased in patients with RA. Patients respond-
ing to chrysotherapy have suppressed phagocytic activity due 
to GST whereas nonresponders did not. Ugai et al. (1979) 
found the incubation of GST (25 ug/ml) with monocytes in 
vitro caused a morphological change, aurosomes, and that the 
phagocytic activity was decreased without significant effect 
of viability or adherence. The suppression of phagocytosis 
by gold salts and prednisolone were qualitatively similar 
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though quantitatively gold is less potent, has a slower on-
set of action and longer duration of action (Roberts et al., 
1973). Even though both gold and steroids are used to treat 
RA, steroids do not prevent the progression of the disease 
(Harvey, 1975). 
iii. Lymphocytes. - GST, at pharmacologically 
relevant concentrations, inhibited mitogen and antigen in-
duced proliferation of T-lymphocytes (Lipsky and Ziff, 1977). 
T-Lymphocytes previously stimulated with concanavalin A were 
not inhibited by GST. Monocytes reversed the inhibition but 
preincubation of gold with monocytes interfered with the 
functional capabilities of the monocytes. 
The fact that organic gold therapy impinges on several 
target systems involved in the generation of the rheumatoid 
process may be a critical factor accounting for its tolerable 
or acceptable therapeutic index. An overwhelming effect on 
any one of these critical functions would be associated with 
unacceptable toxicity to the patient. Thus, the proven 
therapeutic benefit derived from chrysotherapy in the man-
agement of rheumatoid arthritis may be dependent on a spec-
trum of pharmacological effects expressed on the different 
biological components contributing to the rheumatoid pro-
cess. 
4. Other gold compounds. 
Metallic gold is ineffective as an antirheumatic 
drug. Gold chloride is effective but too toxic (Freyberg, 
1972). The thio-gold compounds were originally used because 
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of their solubility (Jaffe, 1977) and have since been found 
to be more effective and less toxic than nonsulfur contain-
ing gold compounds (Freyberg, 1972). 
a. Gold thioalucose. 
Gold thioglucose is used to treat RA. In mice 
and guinea pigs gold thioglucose accumulates in the ventro-
medial hypothalamus and causes obesity (Dalferes et al., 1975 
and Chang and Persellin, 1968). Herman et al. (1972) found 
gold thioglucose added to mouse fibroblast cultures increased 
anphagic vacuoles with lipid droplets. 
b. Auranofin. 
A new gold compound, still in phase III clini-
cal trials, SK&F D39162, S-triethylphosphine gold 2,3,4,6 
tetra-O-acetyl-1-thio-B-D-glucopyranoside, auranofin, can be 
taken orally rather than the intramuscular injection re-
quired for GST. Like GST, auranofin has been shown to be 
efficacious in the adjuvant rat model (Walz et al., 1976) 
and with RA patients (Finkelstein et al., 1976 and 1980). 
GST was shown to inhibit lysosomal enzyme activity (Presellin 
and Ziff, 1966 and Ennis et al., 1968) but not enzyme release 
(Ennis et al., 1968 and Pepper et al., 1974). Auranofin 
blocks release of leukocytes lysosornal enzymes (DiMartino 
and Walz, 1977 and Finkelstein et al., 1977). DNA and pro-
tein synthesis in lymphocytes (Finkelstein et al., 1977) and 
Hela cells (Simons et al., 1979) were inhibited by auranofin. 
With lymphocytes, the transport mechanism was inhibited as 
demonstrated by [ 3H]-2-deoxy-D-glucose but, not with Hela 
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cells. Morphological changes with auranofin include aurosome 
formation (Thomas and Ghadially, 1977) and surface blebbing 
on Hela cells (Simon et al., 1979). Thus, the spectrum of 
auranofin effects reveals both similarities and differences 
compared to GST. It is not known if both GST and auranofin 
have the same mechanism of action in RA. 
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III. .METHODS 
A. Materials 
All chemicals used in this investigation were reagent 
grade or better. For cell culture: Dulbecco's modified 
eagles medium (D.ME), fetal calf serum (FCS), penicillin-
. . 
streptomycin, fungizone, trypsin and trypan blue were all 
obtained from Grand Island Biological Co., Grand Island, 
N.Y. Tissue culture flask$,test tubes and pipets were from 
Corning Glass Works, Corning, N.Y. Gentamycin was from 
Schering Corp., Kenilworth, N.J. Ascorbate 6-aminopropio-
nitrile (BAPN) and ethylenediaminetetracetic acid (EDTA) 
14 
were all from Calbiochem, Los Angeles, Ca. Isotope [ C] 
proline (260 Ci/mole, 2-3 .( 3H]proline (25 Ci/mole) and ·[3H] 
thymidine [ 3HJ TdR(542 Ci/mole) were all from New England 
h . . 11 . k . 1 d ' TM Nuclear, Boston, Ma. T e sc1nt1 ation coc tai , Hy remix, 
was from Yorktown Research, Miami, Fl. Enzymes used were: 
ribonuclease (bovine pancrease, A grade, 65000 U/mg) from 
Calbiochem, Los Angeles, Ca., pepsin (2500 U/mg) from Wor-
thington Biochemical Corp., Freehold, N.J., and bacterial 
collagenase (2600 U/mg) from Advance Biofacturers Corp., 
Lynbrook, N.Y. For the nucleic acid assay DNA (calf thymus, 
type I), RNA (yeast, type XI) and ethidium bromide were 
all from Sigma Chemical Co., St. Louis, Mo. Carboxymethyl 
cellulose (CM-52) was from Whatman, Kent, England. For 
polyacrylamide gel electrophoresis, electrophoretic grade: 
sodium dodecylsulfate (SDS), acrylamide, N,N' methylenebis-
acrylamide (BIS), N,N,N',N'tetramethylenediamine (TEMED) 
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and ammonium peroxydisulfate were all Eastman Kodak Co., 
Rochester, N.Y. Acetone (spectrometric grade) and B-mercap-
toethanol were both from Aldrich Chemical Co., Milwaukee, Ws. 
The fluor 2-methoxy-2,4-diphneyl 3(2H) furanone (MDPF) was 
from Hoffman La Roche, Diagnostic Division, Nutley, N.J. 
Glutaraldehyde for cell fixation was from Eastman Kodak Co., 
Rochester, N.Y. Gold sodium thiomalate (GST) was from Merck, 
Sharp & Dohme, West Point, Pa. 
B. Culture Method 
Synovial tissues were obtained from patients with RA 
who were undergoing reconstructive joint surgery at the 
Roger Williams General Hospital, Providence, R. I. Synovial 
tissue identified as rheumatoid was obtained from patients 
fulfilling the American Rheumatism Association criteria for 
rheumatoid arthritis. The rheumatoid patients had advance 
erosive stages of the disease that required surgical inter-
vention. In all cases, histological examination of the ex-
cised tissue revealed chronic synovitis consistent with 
rheumatoid arthritis. 
The tissue obtained during surgery was dissected free 
of any excess fat, capsular and cartilage tissue, and fine-
ly cut into approximately lmm3 pieces; about fifteen tissue 
pieces were placed in each 100 x 20 mm tissue culture dish. 
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The cultures were incubated at 37° in the presence of 95% air 
and 5% carbon dioxide. The cells were grown in Dulbecco's 
Modified Eagles (DME) medium containing 10% (v/v) heat de-
natured fetal calf serum (FCS) plus 100 units penicillin 
and 100 ug streptomycin/ml medium or gentamicin sulfate (50 
ug/ml medium) and Fungizone (2.5 ug/ml medium). After one 
or two weeks the cells could be seen migrating outwards from 
the tissue pieces and after approximately four weeks the 
cells became confluent and were subcultured into 75 cm2 tis-
sue culture flasks. To subculture (passage) the cells, the 
medium and original tissue fragments were removed by suction 
and the cell layer removed from the dish by incubation for 
five minutes in isotonic phosphate buffered saline (PBS) 
(ph 7.0) containing 0.1% trypsin 0.2 mg/ml glucose and 0.2 
mg/ml ethylenediaminetetraacetic acid (EDTA) . After detach-
ment, the cells were resuspended in fresh medium and re-
plated. Two weeks after the first passage the synovial cells 
were subcultured again and this time replated at one-third 
of their confluent density. The cells were usually conflu-
ent again and subcultured after a further two-week period. 
The cell medium was normally replaced with fresh media every 
4-6 days. All experiments were performed with cells during 
second to fifth passages. The cell cultures were tested 
for and found to be free of mycoplasma contamination using 
a fluorescent assay (Bioassay Systems, Cambridge, MA). 
Gold sodium thiomalate (GST) was diluted in sterile 
distilled water. A 0.01 vol. of drug solution was added to 
culture medium. 
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C. Cell Number Determinations 
1. Hemocytometer. 
With the hemocytometer determinations, cells were 
diluted with medium and both sides of a hemocytometer (Amer-
ican Optical) were filled. The four corner squares and cen-
ter square from eacp side was counted. To determine the 
viability of the cells a 1:1 (v/v) of 0.04% trypan blue was 
added to diluted cells which were then counted as described 
above. Dead cells retained the dye and appeared dark blue 
under the microscope. 
2. Coulter counter. 
For Coulter counter determinations, cells were di-
luted with filtered PBS and the total number of particles 
in the channels calibrated from 10-60 microns diameters 
were used for cell counts. Mean cell size was determined 
by multiplying the number of particles in each channel by 
the mean particle size of that channel. The product, the 
total cell layer volume, was divided by the total number of 
cell particles. 
D. DNA Assays 
1. Ethidium bromide. 
The DNA content of the cell layer was assayed by a 
modified method of Prasad et al. (1972). The cell suspen-
s±on was sonicated twice at 50 watts for 10 seconds. A 
0.1-0.5 ml aliquot of the cell sonicate was added to 10X75 
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disposable test tubes. The total volume was brought up to 
0.5 ml with PBS. An equal volume (0.5 ml) of 20 ug ethidium 
bromide/ml PBS (pH 7.5) was added. The fluorescence in the 
test tubes was determined in an American Bowman spectro-
photometer at an excitation of 360 nm and an emission of 
590 nm. The RNA was digested by adding 10 ul of 20 mg ribo-
nuclease H2o then incubating at 50° for 30 min. The fluor-
escence due to the RNA in the cells was found to be minimal 
in the assay. Therefore, the RNA digestion step was elimi-
nated. DNA was dissolved in phosphate buffered saline (PBS) 
.pH 7.5 and 1-5 ug/tube were used as standards. 
2. [ 3H]Thymidine 
The rate of DNA synthesis was mea~ured by adding. 
0.5 uCi[ 3H]thymidine( [ 3H1TdR)/ml medium 4 hr before harvest-
ing the cell layer. Cells were released from the dishes 
using the trypsin solution described above and precipitated 
twice in a 10% (v/v) trichloracetic acid (TCA) solution. 
Precipitent was separated from supernate by 3000g centri-
fugation for 30 min. The TCA pellet was dissolved in 1 ml 
of 0.05 N NaOH, and radioactivity was determined in a 
Packard Tricarb liquid scintillation counter. 
E. Gold Determination-Atomic Absorption 
The amount of gold in the sonicated cell layer was de-
termined using a Perkin Elmer model 460 atomic absorption 
spectrophotometer. Gold sodium thiomalate (GST), 50% (w/w) 
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gold was diluted with water as the standard. The linear 
range was from 5-50 uM. The cell sonicates were diluted 
with water and absorption measured at 242.8 nM. A quanti-
tative increase in absorption was found by spiking the 
biological samples with known quantitates of GST as an in-
ternal standard. 
F. Collagen and Noncollagen Protein Synthesis 
Flasks of synovial cultures were incubated for 24 hrs 
with D.ME medium containing 2,3[ 3H]proline 10 mci/ml S -amino-
propionitrile (BAPN) 100 ug/ml ascorbate 100. uM. The medium 
was removed and dialyzed exhaustively at 4° against O.lM 
tris-HCl buffer pH 7.4. The cell layers were trypsin re-
leased and cell number or DNA content determined as described 
above. 
3 3 The measurement of [ H]collagen and [ H]noncollagen 
protein synthesis was determined by the collagenase digest-
ible protein assay as described by Peterkof sky and Diegel-
man (1971) . Bacterial collagenase was confirmed to be pro-
tease free by the failure of the enzyme solution to degrade 
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c-tryptophan-labeled Echerichia coli protein. (Collagen 
does not contain tryptophan.) From the dialyzed medium a 
0.1-0.5 ml aliquot, +100 units bacterial collagenase were 
incubated for 3 hrs at 37°. The incubation medium, 0.8 ml 
total volume, contained 0.25 rnM CaC1 2 , 2.5 rnM NEM and 0.2M 
Tris HCl pH 7.4. At the end of the incubation, 0.1 ml 1% 
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bovine serum albumin (BSA) and 0.1 ml TCA (50%) were added. 
The precipitates and solutions were chilled at 4° for 1-24 
hrs. After centrifugation, 3000g for 30 min, the supernate 
was removed and 0.1 ml BSA (1%) was added for a second pre-
cipitation. After a second centrifugation of 30 min at 
3000g the supernates were placed in 10 ml of Hydromix™ and 
radioactivity determined. 
The percent collagen was calculated according to the 
following formula: 
% Collagen= ~~~~-:-~~~~~<C_P_M-=-[3_H~}~p~r_o_l~i~n~e:........:i~n:........:c~o~l~l~a~g~e~n~)~X~l~0~0~~~~~~-
5. 4X(CPM [3H]proline in noncollagen)+(CPM[ 3H]proline in collagen) 
'Where the total protein equals the dialyzed medium CPM, the 
collagen protein equals the CPM of supernate with collagen-
ase minus the supernate CPM without collagenase and the non-
collagenase protein equals the total protein minus collagen 
protein. When the pellets were analyzed total protein equals 
CPM of pellet with collagenase and collagen protein equals 
the total protein minus noncollagen protein. The pellet 
method is variable because the quantitation of collagen is 
a small difference between two large numbers, as opposed to 
the supernate method. The above formula accounts for the 5.4 
times greater amount of praline in collagen than in non-
collagen protein. 
G. Medium Collagen Assay for Type I and III Collagen 
1. Extraction. 
Cells in 75 cm flasks were incubated with 10 ml of 
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fresh medium containing B-aminoproprionitrile (BAPN) (l0- 4 
g/ml) and ascorbate (10- 4M). Ascorbate was added to the 
flasks every day during the incubation period. r14c]pro-
line or 2,3[ 3H]proline (1 uCi/ml medium) was added 48 to 72 
hrs before the medium was harvested. Labeled praline in-
corporation in this system was found to be linear over a 
72 hr period. In the presence of BAPN to inhibit collagen 
crosslinking and ascorbate to ensure hydroxylation, the 
amount of radioactive collagen present in the cell layer 
was below the limit of detection of the collagenase diges-
tion assay (Kuttan et al., 1979). In view of this, these 
studies were conducted on collagen harvested only from the 
medium; the cell layer was used for the cell proliferation 
studies described above. Medium protein was precipitated 
by adding ammonium sulfate crystals to 45% saturation. Af-
ter overnight incubation at 4°, the precipitate and solution 
were centrifuged at 3000 g for 30 min. The pellet (which 
contained more than 95% of the nondialyzable hydroxyproline) 
was dissolved in 1 ml of 0.5 M acetic acid and then dial-
yzed in the cold at 4° against 0.5 M acetic acid. Pepsin 
(100 ug/ml) was added to the dialysis bags to digest non-
collagen protein and convert procollagen to collagen. Di-
alysis was continued for another 2 days and the samples 
were then lyophilized or dialyzed against .05M sodium 
2. Sample preparation for electrophoresis. 
Samples were prepared for electrophoresis as 
42 
described by Goldberg and Fuller (1978) by dissolving them 
in 0.05 M sodium phosphate (pH 7.2) containing 0.2% sodium 
dodecylsulfate (SDS) and 10% sucrose. The pH was adjusted 
with sodium hydroxide and the proteins were made fluores-
cent by the addition (with mixing) of 0.2 vol. of a 2-4 mg 
MDPF*/ml acetone solution. Disulfide bonds of type III 
collagen were reduced (R) by heating the alkaline samples 
(pH = 10-11) at 56° for 15 min. Nonreduced (NR) samples 
were prepared by returning the fluorescent samples to neu-
trality (pH = 7-8) with hydrochloric acid before heating. 
3. Electrophoresis procedure (MDPF-SDS-PAGE) 
Samples were electrophoresed according to the pro-
cedure of Neville (1971) • This is a discontinuous Tris-
borate buffer system with SDS only in the upper buffer and 
sample preparation buffer. The upper buffer is 0.5% Tris, 
0.25% boric acid and 0.1% SDS. The lower buffer is 0.15M 
Tris-HCl pH 8.5. The gels (5mm x 55mm) used to separate 
collagen components were 6% acrylamide, 1% N,N'-methylene-
bisacrylamide (BIS), 0.05% ammonium peroxy-disulfate, 0.1% 
N,N,N',N'-tetramethylendiamine (TEMED) and 0.15M Tris 
HCl pH 8.5. The stacking gels were 4% acrylamide, 3.3% 
Bis, 0.1% TEMED, 0.05% ammonium peroxydisulfate and 0.04M 
Tris-HCl pH 6.1. The samples were electrophoresed (Buchler 
Instruments) into the stacking gels (0.5-1.0 h), at 0.2 
mAmps per tube; the current was increased to 1.0 mAmp per 
* MDPF=2-rnethoxy-2,4-diphenyl-3-(2H)-furanone. 
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tube for electrophoresis in the running gel for 2.5-3.5 at 
room temperature. 
4. Quantitation of collagen types I and III. 
a. Scanning procedure. 
The quantitation of fluorescence in the gels 
was determined as described by Goldberg and Fuller (1978). 
After electrophoresis the gel tubes (containing gels) were 
either sealed with parafilm and stored at 4°C or placed in 
the gel tube holder of the Gilford linear transport gel 
scanner. Fluorescence scanning was done with a Gilford 250 
spectrophotometer equipped with a Corning 840 recorder, a 
Gilford 2520 gel scanner, and the Gilford 2515 fluorescence 
gel accessory. The Model 2515 has a light source and ex-
citation filter to provide an excitation energy at 390 nm 
at right angles to the optical path of the spectrophotometer; 
the emission filter placed between the gel tube and the 
photometer allows emission light to pass through at 480 nm. 
The Model 2515 also includes a signal converter which per-
forms an antilog conversion of the photometer signal. There-
fore, · the recorded signal is proportional to the light re-
ceived. To standardize measurements, standard quinine so-
lutions in gel tubes sealed with parafilm were placed in 
the linear transport. By adjusting the recorder span con-
trol the pen of the recorder was set to record the output 
of the spectrophotometer in accord with the following equa-
tion: 
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RFI = log-l (2 - Abs.) 
where RFI is the relative fluorescent intensity measured by 
the percentage of pen movement. Abs is the absorbance units 
read from the Gilford spectrophotometer Model 250. 
b. Fluorescence of band. 
The gels were scanned at 2 cm/min with a 
chart speed of 4 cm/min. The areas under the peaks were 
quantitated using a Numonic Electronic Planimeter Model 
210-117, with peak area given in square centimeters. (Full-
scale pen deflection on the Corning recorder was 25 cm.) 
The fluorescence in the gels was quantitated by the follow-
ing equation: 
RFI x mm = area (cm
2) x gel scan rate (cm/min) x 10 (mm/cm) 
scale factor (cm/RFI) x chart speed (cm/min) 
where RFI x mm is the relative fluorescent intensity cor-
rected for band width on the gel. Increasing the instrument 
scale factor results in a linear increase in sensitivity of 
the recorder thereby increasing pen deflection (cm) per 
unit of RFI. The area under the peaks recorded from fluoro-
metric scanning of MDPF-labeled a. l (I), a. 2, and ·a.1 (III) 
was linear from 10- 5 to 10-a g. The standard curves for 
the three a. chains were similar. The results from nonrepli-
cate determinations had an SE of + 6. Using a standard 
curve from purified a. l(I) calf skin collagen, the fluores-
cent area (RFI X mm) of synovial cell medium MDPF-labeled 
collagen was converted to amount of collagen a. chains. 
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c. Radioactivity of bands. 
The radioactivity in the bands corresponding 
to chains was determined by dissolving 5 mm slices in 0.2 
ml hydrogen peroxide and then heating at 60° for 4 hr or at 
37° overnight. Ten milliliters Hydromix™ were added to the 
vials,. and the radioactivity was determined in a Packard li-
quid scintillation counter. 
T~e ~ercentages of type I and type III collagen in SDS 
polyacrylamide gels were calculated from the following formu-
las: 
3 
x 100 % Type I = a1 (R) 
a2 (R) + 1 
a1 (R} a1 (NR) 
% Type III = a2 (R) a2 (NR) x 100 
al (R) + 1 a2 (R) 
where al (NR) and a2 (NR) are CPM found in the gel slices or 
fluorescence found in the peaks at the al and a2 chain posi-
tions, respectively, after electrophoresis of a nonreduced 
sample; and where al(R) and a2(R) are the CPM found in the 
gel slices or fluorescence found in the peaks at the al and 
a2 chain positions, respectively, after electrophoresis of 
a reduced sample. 
H. Carboxymethyl Cellulose Chromatography (CMC) of 
Collagen 
Collagen [14c]labeled samples were analyzed by car-
boxymethyl cellulose chromatography, using the procedure 
described by Miller (1976). A 1.8 x 10 cm column (Pharmacia, 
Uppsala, Sweden) was filled with carboxymethyl cellulose 
equilibrated in 0.06 M sodium acetate buffer (pH 4.8) and 
14 
maintained at 42°. The C-labeled collagen samples, con-
taining 2-4 mg of type I and type III calf skin collagen 
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(prepared as described previously (Fujii and Kuhn, 1975)) as 
carrier, were denatured by heating at 56° for 30 min in the 
presence of 10 M urea. The samples were reduced by the ad-
dition of 1% (v/v) B-mercaptoethanol and applied to the 
column. The collagen a chain components were eluted from 
the column using a linear salt gradient; the starting buffer 
consisted of 200 ml of 0.06 M sodium acetate buffer (pH 4.8), 
and the final buffer consisted of 200 ml of starting buffer 
containing 0.1 M sodium chloride. The eluant was collected 
in 12-ml fractions; 1 ml of each fraction was mixed with 10 
ml Hydromix™ and the radioactivity was counted. The per-
centages of type I and type III 14c-labeled collagen were 
calculated from the radioactivity eluted in the peaks that 
correspond to al(l), al(III) and a2 chains. The al(I), 
al (III) and a2 :_Jpeaks were confirmed by their electrophoretic 
migration on SDS-polyacrylamide gels. 
I. Purification of Type I and III Collagen Standards 
The procedure adopted for the purification of collagen 
was that of Fujii and Kuhn (1975) . Skin from a newborn 
calf was extracted in cold 0.05M Tris-HCl pH 7.5, lM NaCl 
for several days. The insoluble material was extracted in 
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the cold, with 10% acetic acid for several more days. The 
remaining skin and extract were both lyopholized. Freeze-
dried skin, lOOg, was rehydrated in 25 1 of 0.1% acetic acid 
pH 2.0 (adjusted with HCl), 25.0 g pepsin was added slowly 
with stirring, after 24 h 17.5 g pepsin was added for a fur-
ther 24 h digestion at room temperature. 
The solubilized material was filtered through sintered 
glass wool. Sodium chloride crystals were added to the fil-
trate to give a final concentration of 0.9M sodium chloride; 
the mixture was allowed to stand overnight at 4° C. The 
collagen that precipitated out was collected by continuous 
centrifugation at 15,000Xg for 1 hr. The pellet was resus-
pended in 0.5M Tris-HCl pH 7.5, to inactivate the pepsin for 
four days, and then centrifuged at 35,000Xg for 1 hr. The 
supernatant was lyopholized. 
Differential salt precipitation (DSP) was performed 
to harvest the pepsin released Type I and Type III collagen; 
30g of the freeze-dried supernatant was dissolved in 10 1 of 
.05M Tris-HCl pH 7.5, lM sodium chloride. Sodium chloride-
(4M) was added to make a final salt solution of l.7M sodium 
chloride. The volume of 4M NaCl added was determined by the 
following equation: 
C . V. + CV = Cf(V . +V ) 
1 1 a a 1 a 
where Ci is the initial salt concentration (lM), Vi is the 
initial volume (10 1), Ca is the added concentration of salt 
(4M) and Cf is the final desired salt concentration (l.7M). 
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The equation is . solved for V which is the volume of 4M sodi-
a 
um chloride added. The solution was allowed to stand for 
24 hr at 4° and then centrifuged at 35,000Xg for2 hr. The 
precipitant was washed by centr~fugation three times in 0.5 M 
Tris-HCl pH 7.5, l.7M NaCl. It was resuspended in 1% acetic 
acid and dialyzed against 1% acetic acid, and then centri-
fuged at 55,000Xg for 1 hr. The supernatant was lyopholized 
and characterized as type III collagen by further purifica-
tion gel electrophoresis, and cyanogen bromide peptide map-
ping. The salt concentration of the supernatant was then 
increased as described previously, again this time from l.7M 
sodium chloride to 2.5M sodium chloride with 4M sodium chlor-
ide. The resulting precipitant was allowed to settle for 24 
hr and harvested by centrifugation at 35,000Xg for 2 hr. The 
pellet was resuspended in 1% acetic acid dialyzed against 1% 
acetic acid and then centrifuged at 55,000Xg 1 hr. The 
supernatant yielded lOg of Type I collagen. The collagen 
was characterized by further purification, gel electrophore-
sis, and cyanogen bromide peptide mapping. 
J. Phase Contrast Photomicrographs 
Phase contrast photomicrographs of cells in growing 
monolayers were obtained using an American Optical inverted 
microscope equipped with Expo star automatic shutter control 
format 35mm (2.8X), ASA 16 and Reciprocity B. The film 
used was Kodak high contrast copy film HC135-36. 
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K. Electron Microscope (EM) 
Three types of preparations were used to examine synovial 
cells and tissue with the EM. Osmium stained preparations 
which stained membranes were used to examine ultrastructures 
and for X-ray probe analysis. 
1. .Nonosmium procedure. 
For the n.onosmium treated preparation, 1 cells were 
fixed in the culture dishes with 1.6% (v/v) gluteraldehyde-
PBS pH 7.3 for 30 min at 4°. The cell layers were scraped 
off with rubber policemen, transferred to a 15 ml conical 
centrifuge tube and centrifuged at 2,000 RPM for 5 min. The 
pellets were resuspended in 200 ul of PBS pH 7.3 and trans-
f erred to a 400 ul microcentrifuge tube (Eppendorf) . The 
pellet was washed three times by centrifugation, 8000 RPM 
for 5 min. A drop of PBS, approximately half the volume of 
the pellet, was added after the last wash to maintain mois-
ture. The samples were dehydrated with alcohol and epon em-
bedded. Sections, using a Sorvall MT-1, were stained with 
uranyl acetate and lead acetate and examined with a Siemens 
101-TEM. 
2. Osmium procedure. 
For osmium fixed cells, 2 the cells were first fixed 
1The EM work was conducted by Dr. Elizabeth LaDuc at 
Institut de Rechurches sur le Cancer, Boite #8, 9480 Ville-
jif, France. 
2 The EM work was conducted by Grant Jolly at the Roger 
Williams General Hospital, Department of Pathology, Providence, 
Rhode Island. 
so 
with 1.5% gluteraldehyde in O.lM sodium cacodylate buffer and 
then post fixed in 1% osmium tetroxide in O.lM sodium cacody-
late buffer. The cell pellet was embedded in epon and 1 mic-
ron sections were stained with toladine blue. Ultra-thin 
sections (60 nM) were cut using a LKB ultratome III then 
stained with uranyl acetate and lead citrate. Representative 
photomicrographs were taken with an RCA EMU-4C. 
3. X-ray probe analysis. 
For X-ray probe analysis 3 cells were fixed in 2% 
gluteraldehyde, 2% parafermaldehyde-Cacodylic acid buffer. 
An energy level of 75 KeV in a Hatachi HS00-1 was used to 
obtain the L and M shells for gold. 
L. Statistics 
Linear regression lines for plots were drawn using a 
Hewlett Packard XY plotter model 9862A connected to a 
Hewlett Packard model 10 calculator. A Texas Instrument 
SR-52 programmable calculator was used for statistical ana-
lysis. 
1. Mean: x = 
L: x. 
1 
n 
i=l, 2, ... , n 
3The X-ray probe analysis was conducted by Philip McGrath 
and John Ewell at the Bureau of Biologics, Division of Path-
ology, Food and Drug Administration, Building 29, National 
Institute of Health, Bethesda, Maryland. 
where n = sample size , X. = value for each sample 
l. 
2. Standard error: S.E. = 
2 
I: (X. - X) 
l. 
n(n-1) 
...... "' 3. Linear regression: Y = b
0 
+ b 1 X + e 
a. "' Slope: b 1 = 
[cx.-x) (Y.-Y) 
l. l. 
A A 
b. Intercept: b
0 
= Y - b 1 X 
c. Correlation coefficient r = 
4. Student t test 
t(n-2) = 
rcx.-x) (Y.-Y) 2 
. l. l. 
x. -X) 2 f(Y. -Y) 2 
l. l. 
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5. One way analysis of variance (ANOVA) with completely 
randomized design. 
a. 
Degrees of 
Source Freedom 
Treatment K-1 
Error n-K 
Total n-1 
i=l,2, ... ,N 
ANOVA TABLE 
Sum of 
Squares 
K ·2 ~ T·J n 
Kn 2 K 
l!Y. . - L 
l. J 
km 
!!Y .. 2 
l. J 
2 T •• /n 
2 
- T •• /n 
j=l,2, ... ,K 
Mean 
Squares 
MS Tr 
MSE 
52 
F 
MSTr/MSE 
F k-1, n - K, 1-o( 
b. Post Hoc ANOVA was Duncan's multiple range test 
p=2 ... K 
6. AP< 0.05 was considered significant. 
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IV. EXPERIMENTAL RESULTS 
A. Morphology 
1. Light microscope. 
When synovial cells were examined by phase contrast 
microscopy, perinuclear vacuoles were observed in the synovi-
al cells which had gold in the medium. In order to determine 
th.e time and concentration dependence on vacuole formation, 
synovial cells were grown in medium containing 250, 125, 100, 
60, 50, 30, 25, 15, 10, and 7.5 uM gold sodium thiornalate 
(GST) containing medium. Cells were observed daily and re-
presentive photomicrographs were taken (Fig. 1). The onset 
of vacuole formation occurred between 2-3 days for concentra-
tions between 250-lOOuM. The number and the size of the 
vacuoles increased with time of incubation to a maximum ob-
served at 5-7 days when most of the cells had vacuoles. 
There was also a decrease in the observed number of cells in 
the cultures. If the gold (250-lOOuM) was removed from the 
medium the observed number of cells remained the same and 
the cultures did not grow to confluency even after subcultur-
ing. The number of cells retaining trypan blue did not in-
crease due to the GST exposure (Table 1) . 
Vacuole formation was found at 60 and 50uM GST after 
5-7 days and an increased number and size of vacuoles was 
observed over the following week. The size and number of 
·Fjg. , 1. Phase contrast 
to GST ( 200X) . 
(c) 125 uM GST 
photographs of synovial cells exposed 
(a) control (b) 30 uM GST for 14 days 
for 4 days (d) 125 uM for 7 days . 
V1 
..,.. 
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TABLE l 
EFFECT OF GOLD SODIUM THIOMALATE (GSTl_ ON CELL VIABILITY 
GS Ta Cell 
. b 
Counted Percent c 
(uM) per flask - Viable 
0 157" + 20 C4l a 9 8. 8 + 0.5 
-
10 119 + 7 (_3) 98.3 + 1.2 
-
30 48' + 6 (4 ye 95. 3- + 1.4 
-
100 31 (23-39) f 89 (_83-95) 
- . 
a Cells were exposed to GST for one or two weeks. 
bCells were counted with a hemocytometer. 
cViability was determined by trptan blue exclusion. 
dMean + S.E. Cn = number of flasks) from two experiments. 
e p < 0.01. 
fMean (range) for two flasks. 
vacuoles after two weeks of 60 and SOuM GST were less than 
those obtained for lOOuM GST for one week. Only a minimal 
amount of vacuole formation was obtained from the 30 and 25 
uM concentrations after two weeks of exposure. Synovial 
cells did not develop vacuoles after one month exposure to 
the lower concentrations. 
Exposure of the synovial cells for one week to lOOuM of 
mercury, lead, cadmium, silver, copper, zinc, sodium thio-
malate and gold chloride did not reveal the characteristic 
vacuole formation observed with gold sodium thiomalate (GST). 
2. Electron microscope (EM). 
In order to determine if the vacuoles contained 
gold, cells were fixed with gluteradlehyde at various times 
after exposure to GST. In cultures (lOOuM for one week) that 
presented numerous vacuoles by phase contrast microscopy, 
many such vacuoles were found with electron dense material 
by EM (Fig. 2). At the low GST concentration (lOuM for one 
week) that did not have any evident vacuoles by light micro-
scopy, only a few electron dense vacuoles were found after 
examining many cells. X-ray probe analyses confirmed that 
the electron dense material in the membrane bound vesicles 
is gold. 
a. In vivo and in vitro aurosomes. 
Oryshak and Ghadially (1976) named the membrane 
bound vesicles of gold found in cells aurosomes. Fig. 3 is 
a comparison of aurosomes observed both in vivo and in vitro. 
Fig . 2 . EM photograph of aurosome and X-ray probe ana-
lysis. Cells were stained with osmium . A por-
tion of the nucleus is in the upper right-hand 
corner . Beneath the nucleus is a golgi apparatus . 
Three longitudinal sections of mitochondrias are 
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to the left of the golgi . Electron dense areas i n 
the membrane bound vesicles had an X-ray probe 
analysis for gold , lower left. The bars in the cen-
ter are the theoretical lines for the L&M shell 
of gold. Beneath the bars is the scan of an elec-
tron dense area . The large peak in the center is 
from the copper in the copper grid . 
Fig . 3 . In vivo and ~n Vitro aurosornes . Synovial tissue 
Ta and b ) anc:r-synovial cells (c a nd d) were not 
osmium stained . (a) In the lower right-hand cor-
ner is collagen ; in the upper right-hand corner 
is the nucleus . The many electron dense areas 
to the left of the nucleus are go ld aggregates 
in a lysosome . (b) Aurosome to the right of 
the nucleus. (c) and (d) Electron dense gold 
a9gregates in the lysosomes of synovial cells 
in culture . 
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The patient donor of this section had been receiving gold 
therapy for 2 years and had discontinued gold therapy for 
several months before synovectomy. The aurosome structures 
are nearly identical in both the sections of synovial tissue 
and in the gold induced aurosome in the cultured synovial 
cell. 
b. Genes·is of the aurosome in culture. 
Fig. 4 is· a proposed sequence in the develop""" 
ment of an auros.ome. First the gold is precipitated with 
proteins. to form an electron dense aggregate ·outside the 
cell. The gold aggregates are phagocytosed or pinocytosed. 
Th~ protenous core is broken down Cpossibly by enzymes) and 
plate-like structures and small round electron spheres or 
rods in cross-sections :Oecome numerous. Eventually the pro-
posed protenous core is diss-ol ve.d leaving just aggregates 
of lamellae structures-. 
c. Nuclear change. 
The expos·ure of cultured synovial cells to 
GST (_125 uMI results in a nuclear change. Chromatin clump-
ing near out not attached to the nuclear envelope. occurred 
in s-ome nuclei (_Fig. Sf. This was not found as consistently 
as aurosorne formation. An anti-malarial drug quinaqrine can 
cause s·imilar nuclear changes (LaDuc ·et · al~ .1 manuscript in 
preparation) • Anti-malarial drugs are also second-line 
drugs us~d in RA. 
Fig . 4 . Genesis of aurosomes . Cells were not osmium 
stained . (a) An electron dense aggregate is 
pinocytosed . (b) Many small particles break 
off the electron dense material in a lysosome. 
(c) Lamellae structures form in the lysosome . 
(d) The protein core is dissolved . 
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' 
-Fig . 5 . 
··--- -
GST induce d nucleus change . The cells were stained 
with osmium. (a) A control synovial cell nucleus 
with two nucleoli . (b) A nucleus in a synovial cell 
that was exposed to 125 uM GST for one week . One 
nucleoli is in the nucleus with many electron dense 
areas (clumped chromatin) near the nuclear membrane. O'\ 
f-' 
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B. Biochemistry 
1. Proliferation. 
Because GST has· been shown to prevent the progression 
of the pannus (Sigler et al., 1974} in RA, the effect of GST 
on the proliferation of synovial cell cultures was studied. 
Clinically, tfie effect of gold i~ persistent but not permanent, 
therefore, the reversibility of GST effects on synovial cells 
was also investigated. 
a. Cell number and size. 
Fig. 6 demonstrates tfie effect of two GST con-
centrations on the synovial cell growth curve. Cells were 
plated on day zero with 10,000 cells and on day one 25uM or 
250uM GST were added to the medium. The normal doubling 
time of these cells· is approximately 5 days. There was no 
significant difference in cell number after five days of GST 
exposure. After 10 days there was a suppression in cell num-
ber with both concentrations·. After an initial doubling of 
the culture growing with the 250uM GST, there was a continuous 
decrease in the number of cells. When the 250uM GST was re-
moved from the medium after 10 days of exposure, there was 
no change in cell number after 6 days. With the 25uM GST 
containing cultures the cell number increased but at a slower 
rate than the controls. 
GST did not cause a significant decrease in cell viabil-
ity (Table 1) but did s·ignificantly decrease cell number. 
This can be explained on the basis of cell death which causes 
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Fig. 6. Effect of gold sodium thiomalate (G§T) on cell 
growth curve. Cells (105) were plated in 25cm flask on 
day zero. The medium was changed on day 1 with the addition 
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three flasks. Cells were counted using a hemocytometer. 
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was not added after medium change. 
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the cells to detach from the flask. The gold treated cells 
appeared larger than the nongold exposed cells in the hemo-
cytometer. In order to determine if gold caused a change in 
cell size, treated cells were counted using a Coulter coun-
ter. Fig. 7a shows the size and number of particles counted 
in the channels of the Coulter counter. In the presence of 
GST, there was a shift to larger particles and a decrease in 
the number of particles. No clumping was observed at the 
counting orifice. The increase in small particles may be due 
to the presence of gold protein aggregates. This increase in 
cell size and a decrease in cell number was concentration de-
pendent between 7.5-125W.1 GST (Fig. 7b). These concentrations 
are equivalent to the gold concentrations observed clinicly 
in serum and synovial tissue of patients, respectively (Gerber, 
1972; Grahame et al., 1974 and Gottlieb et al., 1972). 
In order to determine if the increase in cell size was 
related to the decrease in proliferation, synovial cells were 
incubated with latex beads (O.Su) and/or GST for 14 days 
(Table 2) . The latex beads increased the cell size but did 
not decrease [ 3H]thymidine ( [3H]TdR) incorporation. GST and 
GST plus latex beads decreased [ 3H]TdR incorporation. A mix-
ture of latex beads and GST caused a decrease of cell size 
when compared to the cell size of cells exposed to la~ex beads 
alone. Ugai et al. (1979) reported GST inhi~its phagocytosis. 
This would account for the decrease in cell volume with the 
mixture of latex beads and GST. 
b. DNA content and rate of synthesis. 
In order to further characterize the antipro-
liferati ve effect of GST on synovial cells, the dose (time and 
TABLE 2 
EFFECT OF LATEX BEADS AND GOLD SODIUM THIOMALATE (GST) 
ON PROLIFERATION AND CELL SIZE 
GST (uM) a 
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Latex a 0 30 60 
Beads b 
(dilution) (3HJ TdRc Cell size d (3H]TdR Cell size ( 3H]Tdr Cell size 
13.31+1.2e 5. 97+0 .13 2.0 8 . oof g 
1:10 11.6 9.17 1.6 8.70 0.8 7.18 
1:20 15.9 9.20 2.0 8.20 1.0 7.27 
a Cells were exposed to GST and latex beads for 14 days. 
bLatex beads (O.Su) were diluted in sterile water and then a 1% (v/v) was 
added to the culture medium. 
c r3Hlthymidine([ 3H]TdR) was the CPM X 10- 3 incorporated into TCA 
precipitable material. 
d . ·3 -3 
Cell size was the mean volume, µ XlO as determined by Coulter counter. 
e Control, mean + S.E. for three flasks. 
fDuplicate determination from one flask. 
gCulture lost. 
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concentration) dependent effect of GST on DNA synthesis and 
accumulation in culture synovial cells were measured. Fig. 
8a shows the effect of a high (lOOuM) and low (lOuM) drug 
concentration on a DNA growth curve. The high and low drug 
concentration inhibited the DNA growth curve in a similar 
manner as found with the cell growth curve (Fig. 6). Removal 
of GST from the medium resulted in only a partial recovery in 
DNA accumulation at the high drug (lOOuM GST) concentration 
and a complete · recovery at the low (lOuM GST) concentration. 
After one month without lOOuM GST in the medium, the culture 
did not grow to· confluency. Fig. 8b shows the concentration 
dependent inhibition of GST on DNA content of flasks after 
5, 15 and 20 days. The curves shift to the left with increas-
ing exposure time again demonstrating that dose is time and 
concentration dependent. 
To confirm the ability of synovial cell proliferation 
to resume normal division rate after removal of lOuM GST from 
the medium,but not lOOuM GST,the dose dependent effect of GST 
treatment on [ 3H]TdR was investigated. The inhibition of 
[ 3H]TdR was concentration dependent (Fig. 9b). Fig. 9a shows 
that the removal of lOuM GST resulted in a return to the con-
trol levels of DNA synthesis. The removal of the high (lOOuM) 
drug concentration illustrates a partial recovery, but the 
continued downward trend indicates incomplete recovery. The 
inhibition of DNA synthesis preceded the inhibition of DNA 
accumulation (Figs. 8a, 9a) which preceded synthesis (Fig. 10). 
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Fig. 8. Dose dependent effect of gold sodium thiomalate (GST) 
on DNA accumulation. (a) Effect of GST on DNA growth curve. 
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after medium change. (b) Concentration and time ef feet on 
DNA accumulation. Each point is a single determination from 
one flask. Each curve is a separate experiment from different 
cell lines. ( e) 5 day exposure, ( •) 15 day exposure, 
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Fig. 9. Dose dependent effect of gold sodium thiomalate (GST) 
on DNA synthesis. (a) Time course for [ 3H] thymidine ( [ 3H] TdR) 
incorporation into cell layer TCA precipitable material. 
Each point is the mean of duplicate flasks percentage of 
duplicate control flasks for days of exposure. Protocol and 
DNA content in Fig. Ba. (b) Concentration effect of GST on 
[3HfTdR incorporation into DNA. Each point is the mean + S.E. 
for three flasks of cells exposed to GST for 5 days. 
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2. Protein synthesis. 
Fig. lOa shows the relative time course for inhibi-
tion of protein synthesis. At lOOuM GST the 50% inhibition 
for DNA synthesis and protein synthesis was 25 and 9 days, re-
spectively. The delay of onset of significant inhibition was 
also longer for protein synthesis (after 5 days) than DNA 
synthesis (after 2 days). 
a. Noncollagen protein and collagen synthesis. 
Fig. lOb shows the concentration dependent inhibi-
tion of collagen and noncollagen protein synthesis. Because a 
limited number of drug concentrations over a narrow range 
were used to characterize the inhibition curve a probit trans-
fermation was used to examine the correlation (r >0.95) between 
drug effect and concentration. Collagen synthesis was in-
hibited at each concentration more than noncollagen synthesis 
(Fig. 10). Fig. llc shows that there is a concentration de-
pendent inhibition of the percentage of collagen synthesized 
with exposure to increasing GST concentrations. 
Both proliferation and protein synthesis were inhibited 
by GST, but the inhibition of proliferation preceded the in-
hibition of protein synthesis. The dose dependent effect of 
GST on collagen per cell and per DNA was biphasic (Fig. 11) 
with first an increase in the amount of protein synthesized 
per cell up to 30uM and a decrease to below control levels 
at higher doses. Using lOOuM GST, a time dependent increase 
in protein per cell was found but this increase was not found 
with protein per unit of DNA (Fig. lla). However, an increase 
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in protein synthesized per DNA content was found at 30uM GST 
after 15-20 days of exposures (Fig. 11). This discrepancy is 
explained on the basis of the higher DNA content per cell 
with increasing GST concentrations (Fig. 12). The increased 
ethidium bromide-DNA fluorescence is not due to GST in the 
sample because the addition of GST to cell sonicates did not 
increase fluorescence in this assay. When cell proliferation 
was arrested by removal of the fetal calf serum (FCS) from 
the medium, an increase in DNA content per cell was also 
found. Thus, increases in cell size and DNA content per cell 
are most likely consequences of proliferation inhibition 
(Greenberg et al., 1977 and Cristofolo and Kritchevsky, 1969). 
Because the anti-proliferative effect of GST is dose depend-
ent for both cell number and DNA, both were used to express 
the cellularity of the culture though cell number is the more 
conservative estimate of the two. Therefore, the increase 
in collagen and noncollagen protein synthesis is more drama-
tic per cell number than per microgram DNA. 
b. Collagen types. 
i. Electrophoresis. - Fig. 13 is a photograph 
of a SDS-polyacrylarnide gel containing purified types I and 
III calf skin collagen standards. Beneath the gel is a den-
siometric scan of the Coomassie blue stained proteins. With 
Coomassie blue, reduced a l(III) migrates a little slower 
than al(I) using the Neville (1971) gel system. With MDPF 
labelled chains the reduced a l(III) and a l(I) migrate to-
gether (Goldberg and Fuller, 1978) . Because BAPN is used with 
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the cell culture system the dimers, S 11 and Sl2, are not 
found in the medium extracts of the cell culture s y stem. Type 
III collagen is held together as a trimer, y , and possibly 
higher molecular weight forms by disulfide bonds. The reduc-
tion of the disulfide bonds removes the y peak and causes a 
concomitant increase in the a l peaks in extracted synovial 
cell medium collagen (Fig. 14). The peaks remaining at the 
top of the gel are the interfaces of the stacking and run-
ning gels. The fluorescence observed between the a and y 
peaks did not contain radioactivity and was not found con-
sistently. 
The fluorescence is the amount accumulated for 5 days; 
the radioactivity reflects the rate of synthesis for the last 
2 days. After 15 days of exposure to GST (7.5-30uM) a dose 
dependent increase in collagens synthesized per cell was 
found using the MDPF-SDS-PAGE separation procedure (Fig. 16). 
This increase in collagen was predominantly type I collagen. 
The increase in collagen content, by fluorescence, and the 
rate of synthesis by the incorporation of radioactivity, were 
similar, indicating that GST was not effecting c14cJ proline 
transport. Becausethe number of cells and percent of collagen 
both decrease at high GST concentrations, not enough collagen 
was extracted to quantitate collagen types at concentrations 
above 30uM GST. 
ii. Chromatography. - Fig. 16 is the CMC chroma-
tograph obtained from synovial cell medium. The arrows re-
present the peaks of purified types I and III calf skin 
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a chains used as standards. The medium collagen was obtained 
from two pooled cultures exposed to 7.5uM GST for 15 days or 
from two pooled control flasks. The small peak between a l(III) 
and a 2 was not seen with the 15uM GST exposed cultures. The 
effect of GST on collagen types as quantitated using fluores-
cence or radioactivity after separation by SDS-PAGE is com-
pared to the results obtained when the radioactive samples 
were separated by CMC chromatography (Table 3) . SDS-PAGE sep-
arates the collagens by molecular weight with type III colla-
gen being the increase in the a 1 position after reduction. 
CMC separates by ionic charge with a 1 (III) being more posi-
tive than a l (I) and less positive than the a 2 chain of 
type I collagen. GST (7.5-30uM) significantly (P < 0.05) de-
creased the percent type III collagen synthesized by about 
50%. This decrease was not found to be dose dependent. The 
estimation of the portion of type III was greater when sepa-
rated by CMC than SDS-PAGE but the decrease in percent type 
III collagen is still evident by both separation techniques. 
(Parrott et al., 1980) using rheumatoid arthritis, osteo-
arthritic and normal synovial cell lines found the estima-
tion of percent type III collagen was greater by CMC than 
SDS-PAGE. These estimates obtained with t he two procedures 
were significantly correlated (P < 0.01). 
3. Reversibility. 
In order to further characterize the reversibility 
of the effect produced by GST, the gold content of cell 
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TABLE 3 
EFFECT OF GOLD SODIUM THIOMALATE(GST)ON THE PERCENT OF 
TYPE III COLLAGEN SYNTHESIZED BY SYNOVIAL CELLS 
GST a Electrophoresis(MDPF-SDS-PAGE) 
UM CP~ F390 
480 
0 32+6c 31+3 
7.5 13+le 10+3e 
15 9+3e 8+3e 
30 13+3e 20+2e 
aCells were preincubated with GST for 15 days. 
GST but continuing BAPN and ascorbate was then 
collagen was harvested 5 days later. 
Chromatography(CMC) 
CPM 
39d 
26 
21 
f 
Fresh meditml without 
added; the medium 
b [14c ]praline was added 2 days before the medium was harvested. 
cMean + S.E. from triplicate flasks. 
dSingle determination from two pooled flasks. 
e p < 0. 05. 
f Insufficient collagen for quantitation. 
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layer sonicates was determined by atomic absorption spectro-
scopy. Fig. 17 shows that GST caused a dose dependent ac-
cumulation of gold associated with the trypsin released and 
sonicated cell layers. These cell layers were washed once 
with PBS and once with 0.1% trypsin PBS pH 7.3, thus, the 
gold detected with the cell layer is in and possibly on the 
surface of cells. The deposition of gold in the cell layers 
has a lag time of a day and is inversely related to the in-
hibition of DNA synthesis (Fig. 17a). The relationship of 
medium concentration of GST to gold in the cell layer is log 
linear (Fig. 17b). When the cell layer volume was estimated 
(by Coulter counter) there was approximately a 1000 times 
greater concentration in or on the cells than in the medium. 
Table 4 shows that the removal of gold from the medium 
causes a decrease in gold associated with the cell layer but 
that complete removal is not achieved after 14 days. Table 
5 shows the recovery of some biochemical parameters after 
the removal of GST from the medium. The recovery of the 
biochemical parameters was not complete but neither was the 
removal of GST from the cell layers. The increase in gold 
content per unit of DNA from experiments 1-3 was linearly 
related to the decrease in the percent of control of DNA 
content (slope = -1. 6, intercept = 79, r = 0. 64, p < 0. 01 
and n = 17 flasks); total protein synth~sized (slope= -1.3, 
intercept 72, r = 0.61 and n = 17); percent collagen (slope 
= -0.93, intercept= 76, r = 0.57, p <0.01 and n = 17). The 
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Fig. 17. Dose dependent accumulation of gold with the cell 
layer after exposure of synovial cells to gold sodium 
thiomalate containing medium. Gold was determined in cell 
layer sonicates by atomic absorption. (a) Time course for 
gold deposition ( e) in or on the cells; ( •) inhibition 
of DNA synthesis; (b) concentration dependent accumulation 
of gold associated with the cell layer after 5 days of 
exposure. Each point is a duplicate determination from one 
(25cm2) flask. 
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TABLE 4 
QUANTITATION OF GOLD ASSOCIATED WITH SYNOVIAL AND SKIN CELL LAYERS 
AFTER EXPOSURES TO GOLD SODIUM THIOMALATE (GST) CONTAINING MEDIUM 
b Molecules gold Days without a Days with Moles gold 
Xl012 Cell GST GST in GST in 
Line (uM) Medium Medium g DNA 
RA-23c (2)d 10/10 17 0 EXP 1 2.0 
(2) 10/01• 9 8 1.2(0.9- 1.5) e 
(2) 30/30 17 0 40 ( 35-44) 
( 2) 30/0 9 8 18 (11-26) 
EXP 2 
RA~l5 (2t3) 10/10 10(2)c+l9(3) 0 0.45(0.43-0 . 46) 
C2t3) 100/0 10 ( 2) 14 (3) 12.0 
EXP 3 
--
RA-16 (2) lOCg 14 0 0.8 
(3) lOL 20 0 0.8 
(.2) lOOC 10 4 38.6 
( 3) lOOL 12 8 4 . 7 
EXP 4 
-PY~Oh (2) 30C 5 0 10.3 
( 3) 30L 5 0 44.1 
aGold was determined by atomic absorption and DNA by the ethidium bromide assay . 
bCells were counted using a hemocytometer. cRheumatoid synovial cells. 
d e f Passage number (2) or (3). Mean (range). Cell 
gGST added to medium during confluency (C) or log phase (L). 
number not determined. 
hSkin cells. 
Cell 
17 
8(7-9) 
400(180-610) 
10 (10-11) 
f 
44 
470 
Xl0-9 
00 
~ 
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TABLE 5 
R,ECOVER,Y OF B"IOCHEMICAL PARAMETERS AFTER GOLD SODIUM THIOMALATE (GST) 
EXPOSED S,YNOVIAL CELLS ARE GROWN IN MEDIUM WITHOUT GST 
DNAb Totalc Golda · Collagen 
c Collagen E;ST treat .... Protei~6 ment CJ1MF --·· (m moles)_ (ug) . ( %) Type III (CPMXlO ) ( %) 
EXP le 
O/Q 0 9.lf 0.38 12.6 18 
(10.2-8.0) (0.36-0.39) (12 .4-12. 8) (16-20) 
10/10 18.3 9.1 0.32 8.7 8 
10/0 8.7 7.6 0.31 9.6 13 
(8. 7-8.6) (5.9-9.2) (0.31-0.31) (9.5-9. 7) (11-15) 
30/ 30 149 3.7 0.13 6.9 7 
(104-193) (3.0-4.4) (O .13-0 .13) (6.8-7 .0) 
30/0 47 3.0 0.21 6.8 9 
(43-51) (2.0-4.0) (0.17-0.24) (4.2-9.4) (4-14) 
EXP 2e 
0/0 0 37.1 4.0 9.8 18 
( 32. 6-41. 6) (3.4-4.6) (9.6-9.9) (14-21) 
10/10 15.0 33.5 3.2 8.2 4 
(32.3-34.7) ( 3 .0-3. 5) (7.5-8.9) 
0/10 14.3 39 3.5 9.9 5 
(37.9-40.0) (3.1-3.9) (8.4-11.4) ( 3-6) 
100/0 44.3 3.7 0.3 3.9 g 
(3.0-4.3) (0.3-0.4) (3.4-4.3) 
aGold was quantitated using atomic absorption. 
bDNA content was determined by the ethidium bromide assay. 
cTotal protein and % collagen were determined by the collagenase di-
gestible assay. 
dcollagen type III % was determined radiometrically after separation 
by electrophoresis. 
eExposure time for Exp. 1 and 2 are the same as that on Table 4. 
f Mean (range) for two flasks. 
8Insufficient collagen for quantitation. 
a 
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percent type III collagen was not linearly related to gold 
content per unit DNA or to gold content of flasks (r = 0.12). 
The correlation coefficients for gold content versus biochem-
ical parameters are not as high as GST medium concentrations 
versus biochemical parameter (r > 0.90). 
4. Effect of GST on Cells during log phase and conflu-
ence. 
In order to detennine the effect of confluency and 
log phase on cells, second passage confluent cells (75 cm2 
flask) were subcultured. After waiting one day for the sub-
cultured cells to attach, the medium of third passage log 
phase cells and second passage confluent cells were exposed 
to GST. Table 6 shows the effect of GST on gold content, 
proliferation, total protein, percent collagen and percent 
type III collagen. The -skin fibroblast doubling time was 
approximately two days, therefore the GST exposure time was 
less than the synovial cells. With the synovial cells the 
percent type III collagen produced was increased during log 
phase growth whereas with the skin fibroblasts the percent 
type III collagen produced was decreased. With both cell 
lines in conf luency or log phase the percent type III colla-
gen decreased due to GST exposures. GST did not decrease 
the DNA content (more than 10%) during confluency, but de-
pressed both when exposed during log phase growth. In sy-
novial cells, GST induced a decrease in the total amount of 
protein synthesized and a decrease in the percent collagen 
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produced during log phase growth. 
5. Anti-rheumatic drugs and effects on GST. 
The effect of hydroxycloroquine, dexarnethasone, 
penicillamine and gold sodium thiomalate (GST) on the percent-
age of type III collagen produced by synovial cells after 10 
days of exposure was measured in order to determine if other 
anti-rheumatic drugs had GST-like effects on synovial cells. 
Again, GST decreased the percentage of type III collagen by 
SQ%; while the other anti-rheumatic drugs did not decrease 
the pe~cent type III collagen synthesized. 
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TABLE 6 
EFFECT OF GOLD SODIUM THIOMALATE (GST) ON BIOCHEMICAL PARAMETERS OF 
SYNOVIAL AND SKIN CELLS DURING LOG PHASE AND CONFLUENCY 
Totale 
GS Ta Goldb DNAC Protein 
(uM) (m moles) (ug) (CPMxl0-6 ) 
a) Synovial cells during second and third 
Confluency 
0 0 19.4g 2.2 
10 22 21.5 2 . 0 
100 725 18.8 1. 7 
Log Phase 
0 0 14.7h 1.3 
10 (0-0) (13. 3-16 .1) 
10 12 0.9 
(9-11) (10 .6-13. 3) (O. 8-1. 0) 
100 38 5.9 0.5 
(38-39) (3.6-8.2) (0. 2-0. 8) 
b) Skin fibroblast during second and third 
0 
30 
0 
30 
0 
221 
0 
234 
23.6 
21.4 
8.4 
5.3 
Confluency 
1.3 
1.6 
Log Phase 
0 . 85 
0.70 
Collagen c 
( %) 
passage (Exp. 
2 . 0 
1.6 
1.1 
4 . 0 
2.6 
(2.2-3.0) 
2.5 
(1. 8-3. 2) 
passage 
3.4 
3.5 
6.4 
3.8 
(Exp. 
3) . 
4) . 
aExposure time for Exp. 3 and 4 are the same as in Table 4. 
Collagen 
Type III 
( %) 
13 
8 
23 
9 
( 7-11) 
31 
4 
17 
3 
bGold associated with cell layer sonicates from (75 cm2) flasks was 
quantitated by atomic absorption. 
cDNA content was determined by ethidium bromide fluorescent assay. 
dCells were counted using a hemocytometer. 
eMedium total protein and % collagen was determined by the collagenase 
digestible assay. 
f 
f Percent type III collagen was determined radiometrically after separation 
by electrophoresis. 
gSingLe determinations from one flask. h Mean (range) of two flasks. 
TABLE 7 
EFFECT OF ANTI-RHEUMATIC DRUGS ON PERCENT TYPE III 
COLLAGEN SYNTHESIZED BY CULTURED SYNOVIAL CELLS 
Drug 
(uM) 
Control 
Hydroxycloroquine 
(10) 
Dexame thaso ne 
~10) 
Control 
Penicillamine 
(20) 
Gold Sodium 
Thiomala te ( 10) 
Type IIIb 
Collagen 
( % ) 
13 + 2d 
19 + 5 
12 + 1 
17 + 5 
-
22 + 2 
7 + 5 
DNAc 
(ug) 
35 + 1 
31 + 1 
27 + 4 
14 + 3 
22 + 5 
18 + 4 
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aCells were ~reincubated with the drug for 10 days, followed by 3 days 
with drug, [~]-proline, BAPN and ascorbate before medium was harvested. 
bType III collagen % has determined radiometricly after separation by 
electrophoresis. 
cCell layer sonicates were analyzed by the ethidium bromide DNA assay. 
<\iean + SE for three flasks. 
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V. DISCUSSION 
The efficacy of chrysotherapy (gold therapy) in induc-
ing the remission of rheumatoid arthritis has been confirmed 
by several controlled clinical studies (Sigler et al., 1974, 
Research Subcommittee of the Empire Rheumatism Council, 1960, 
1961 and Cooperative Clinics Committee of the American Rheum-
atism Association, 1973). The present study demonstrates 
that, in cultures of human synovial cells, gold sodium thio-
malate (GST), at pharmacologically relevant concentrations, 
has a direct effect on cells derived from the synovial tis-
sues of patients with rheumatoid arthritis. Serum gold con-
centrations of 1 to 3 ug/ml have been reported in rheumatoid 
arthritic patients during chrysotherapy. This is equivalent 
to 5-15 uM GST. Synovial tissue gold concentrations are ap-
proximately 20-30 ug/g, which are equivalent to 100-150 uM 
GST. Thus, the concentrations used to treat cells in cul-
ture in these experiments were intermediate between the serum 
and tissue concentrations observed during chrysotherapy 
(Gerber et al., 1972; Mascarehas et al., 1972; Jessop and 
Johns, 1973; Rubinstein and Dietz, 1973 and Gottlieb et al., 
1972; Vernon-Roberts et al., 1976). Lipsky and Ziff (1972) 
have shown that the gold moiety of GST or gold chloride in-
hibits lymphocyte proliferation (thiomalic acid was without 
effect) . None of the GST effects reported here were observed 
when sodium thiomalate was added to the medium. Therefore 
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in accord with Lipsky and Ziff (1977), the gold moiety is re-
sponsible for the observed changes in synovial cell morphology, 
proliferation and collagen synthesis. 
No one experimental model has all the characteristics of 
human RA. The :rrodel used in this investigation to study the 
effects of GST on the proliferative lesion of RA, was the syn-
ovial cell explant cell culture model from human rheumatoid 
synovial tissue. The advantages of this model are: the cells 
used in culture are the cells most likely responsible for the 
proliferative lesion in RA, experiments can be conducted in 
a convenient and controlled manner, and biochemical effects 
due to GST can be detected more rapidly (days) in culture 
than clinical benefit in patients' joints (months). The limi-
tations are: the cells selected are the more rapidly divid-
ing cells, the immunological and inflammatory cells and fac-
tors are not present, and, after subculturing, an extracellu-
lar matrix is reformed by·the synovial cells. These limita-
tions are advantageous in this investigation because the 
focus of this study is on the direct effect of GST on the 
proliferating synovial cells and the extracellular matrix 
formed by these cells. 
This model does not deal with the complex interactions 
of the immunological, inflammatory and synovial cells. Con-
versely, the cell population generated by this culture tech-
nique is heterogeneous (Marsh et al., 1974) so the biochemi-
cal effects measured could be due to a selectivity for certain 
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cell populations. The interpretation of drug induced changes 
in synovial cell metabolism in the flask to the RA joint has 
the limitations of relating an in vitro to an in vivo condi-
tion. 
Protein bound drugs in the serum are usually inactive 
and the amount of free drug is usually correlated with phar-
macological activity. Albumin bound gold and gold denatured 
proteins (Gerber, 1964) may be phagocytosed by gold neutro-
phils and monocytes. This may be another reason in addition 
to increased blood flow, that an inflamed synovium accumu-
lates more gold than a nonrheumatoid joint (Grahme et al., 
1974). The accumulation of gold in kidney, liver and the re-
ticuloendothelial system (Gottlieb et al.) may be due to the 
phagocytosis and filtration of gold aggregated and denatured 
proteins. Thiomalate is more rapidly eliminated than the 
gold moiety of GST (Jellum et al., 1980). Hence, the dis-
tribution of gold in the body may be more dependent upon the 
gold-protein aggregates than upon the free parent compound 
GST. 
The pharmacodynamic receptor(s) for gold has (have) not 
been identified. The fact that gold can form stable coor-
dination complexes with a variety of ligands (sulfur> carbon 
and nitrogen) (Harvey, 1976) would imply an immense number 
of possible binding sites. There are several billion mole-
cules of gold bound per cell (Table 4). Therefore, much of 
the binding, for example albumin, is not related to the mech-
anism of action. 
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GST causes a morphological change in cells both in cul-
ture and in tissues. Exposure of synovial cells to GST con-
taining medium causes dose dependent vacuole formation (Fig. 
1) as observed by light microscopy, which are gold containing 
membrane bound vesicles by EM (Fig. 2) and resembles the auro-
somes in patients' tissues (Fig. 4). In the case of synovial 
tissues observed after administration of GST to RA patients, 
the predominant cell type in which aurosomes occur is a phag-
ocytic macrophage cell type (Fig. 4a & b), whereas in the ex-
plant culture system, the fibroblast like cells contained the 
aurosomes (Figs. 2 and 3). Ghadially (1979) and Norton et al. 
(1968)have previously reported that aurosomes occur in the 
phagocytic cells of the synovium after in vivo exposure to 
GST. The cultured fibroblast like synovial cells used here 
also have phagocytic properties, as demonstrated by the in-
crease in cell size after exposure to latex particles (Table 
2) or following exposure to GST (Fig. 7a) • In the synovium 
the cells more specific for phagocytosis would be expected 
to take up more gold protein aggregates. The kidney, liver 
and adrenals have higher gold concentrations than the syno-
vi um (Gottlieb et al., 1972). Therefore, the highest concen-
tration of gold in a cell type or in a tissue does not iden-
tify the cell or the tissue as the target for the therapeu-
tic agent. 
The macrophage may be involved in both the mechanism of 
action of gold and in the processing of gold for distribution. 
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In the macrophage, the aurosomes could inhibit the degrada-
tive enzymes (Persillin and Ziff, 1966) or inhibit phagocy-
tosis (Ugai et al., 1979). Fig. 3 shows a proposed matura-
tion of the aurosome. The gold precipitants or aggregates 
enter the cell via phage- or pinnocytosis. The protein 
moiety of the aggregates in vacuoles may be dissolved by pro-
teases, thereby leaving low molecular weight soluble gold 
complexes that may interact within either the phagocytic 
cell itself or be passed directly to another cell type (pos-
sibly a type B synoviocyte) and where biochemical changes 
result (Goldberg et al., 1980). Also, a dead phagocyte may 
release gold into the extra cellular matrix where binding 
to the collagen occurs (Adam et al., 1965 and 1968) reforming 
protein aggregates which may then be phagocytized by an ad-
jacent type B sunoviocyte. GST has been shown to interfere 
with the proliferation of lymphocytes by interfering with 
the macrophage function (Lipsky and Ziff, 1977). Macrophages 
process antigens for presentation to lymphocytes for anti-
body and lymphokine production. The possibility exists that 
macrophages assist in the clinical benefit of gold by pro-
cessing gold aggregates and presenting them to a target cell 
(the proliferating type B synoviocyte) , in this way prevent-
ing the growth of synovial cells of the enlarging pannus. 
The hypothesis that processed gold-protein aggregates 
are digested in the lysosomes and may interact with cyto-
plasmic proteins or other cellular components is supported 
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by the gold distribution study of Lawson et al. (1977). In 
the lysosomes they found a wide range of molecular weight 
species, whereas in the cytoplasm several distinct peaks of 
bound gold were found. This finding would be expected if 
high molecular weight gold-protein aggregates were in the 
process of being digested. The low molecular weight gold 
or free gold would leave the lysosome and bind to certain 
proteins with a high affinity for gold. Van De Stadt and 
Abbo-Tilstra (1980) found that at low gold concentrations 
(<l ug/ml) gold preferentially binds to proteins other than 
albumin. Thus, it is feasible that the lysosomes are process-
ing the high molecular weight aggregates by degrading the 
protein moiety and releasing soluble complexes that could 
bind to cytoplasm "macromolecules." 
Heavy metals in general have an antiproliferative ef-
fect, but this is the first time the mechanism of action of 
gold in rheumatoid arthritis has been linked to the antipro-
liferative effect on hyperplastic synovial cells. The onset 
of the antiproliferative effect of GST takes several days. 
No significant difference in cell number was found until 
after 5 days of GST exposure. No significant difference in 
DNA content was found until after 4 days of GST exposure, 
while a change in DNA synthesis was seen after 2 days. The 
onset delay of inhibition of DNA synthesis is correlated 
with the accumulation of gold in the cell layer (Fig. 7). 
This would indicate that gold needs to be internalized 
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(Fig. 3) prior to the inhibition of proliferation or the oc-
currence of aurosome formation. The delay of onset (which 
is observed clinically since several months of gold therapy 
is necessary before clinical benefits are seen) argues for 
the presence of an internal receptor which provides a less 
rapid onset than a cell surface receptor (Passow et al., 
1959). The growth curve for both cell number (Fig. 6) and 
DNA (Fig. 8a) shows continued cell growth for precisely 
one doubling before inhibition by GST. The C3HJthyrnidine 
inhibition preceded the DNA content decrease (Fig. 10) which 
implies inhibition before or during S phase of the cell cycle. 
The DNA content per cell increases with GST implying inhibi-
tion after S phase but before M phase (possibly G2 phase) . 
To determine where in the cell cycle gold inhibits, a cloned 
cell line that can be syncronized would be necessary. To 
date, no clones have been developed from the synovium. The 
inhibition of cell proliferation may be related to the nu-
clear change in Fig. 5. Penney et al. (1976) found 195Au in 
nuclear subcellular fractions though this could have been 
due to lysosomal contamination. Ghadially (1979) reported 
accumulation of bismuth and lead in the nucleus of cells but 
not gold. There has been no report of gold in the nucleus 
by X-ray probe analysis. In the present study, an X-ray 
probe analysis of one electron dense area in the nucleus 
failed to detect gold. This would indicate the majority of 
the electron dense area as chromatin clumps rather than gold 
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but it is also possible there was not enough gold to detect 
by X-ray analysis. Gold may be bound to DNA, RNA or proteins 
in the nucleus but the amount found in the nucleus is far 
less than the gold in the aurosomes. The data presented here 
suggest that aurosomes participate in the transport and pro-
cessing of gold and the primary site of action is the nucleus. 
The decrease in protein synthesis per flask (Fig. 10) 
like proliferation, is an effect common to most heavy metals 
and could be just heavy metal toxicity. However, the change 
in protein synthesis per DNA was byphasic with the transition 
for the concentration dependent decrease the same as the 
threshold concentration for aurosome formation. GST caused 
a concentration dependent decrease in the percentage of colla-
gen to total protein synthesized by synovial cells (Fig. 12). 
Peniacillamine has also been shown to decrease the percent 
of collagen to total protein synthesized by skin fibroblasts 
in culture (Shorn et al., 1979), but the concentration of 
peniacillamine used in culture for this study was far higher 
than those obtained clinically. 
The influence of cell crowding on collagen and protein 
synthesis has been studied in a number of labora~ories. 
Mann (1971) and Steinberg (1978) both found a decrease in 
total protein synthesis and an increase in the percentage of 
collagen synthesized by 3T6 mouse fibroblasts from log phase 
to confluency. Steinberg (1978) found an increase rate of 
collagen synthesis in 3T6 during confluency; Priest and 
Davis (1969) using 3T6 and rat PR105 cell lines and Abe 
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et al. (1979) using guinea pig skin fibroblasts found a de-
crease rate of collagen synthesis from log phase to confluency. 
Both human synovial cells and human skin fibroblast produce 
less protein per unit of DNA during confluency and an even 
greater decrease in collagen protein synthesis was found dur-
ing confluency (Table 6) . Gold depresses the percentage of 
collagen synthesized by synovial cells in both log phase and 
~onfluency and by skin cells in log phase only. 
The increase in collagen synthesized per cell as de-
tected by the collagenase digestable assay (Fig. 12 and 
Table 6) was also found when the medium collagens were sepa-
rated on SDS-polyacrylamide gels (Fig. 15). The increase in 
collagen was found to be predominantly type I collagen with 
the dose dependent increase for type III collagen at a lower 
slope than type I collagen (Fig. 15). The percentage of 
type III collagen to total collagen was found to be lower 
(p< 0.05) in gold exposed (7.5-30 uM) cultures than untreated 
controls when separated by both SDS-gel electrophoresis and 
carboxymethyl cellulose chromatography (Table 3) . 
Hance and Crystal (1978) reported that guinea pig lung 
fibroblasts produce the same ratio of III/I collagens with 
passages and cell density. Parrott et al. (1980) found that 
osteoarthritis, normal and rheumatoid arthritis derived syn-
ovial cells produce a similar ratio of III/I with passage. 
With the osteoarthritis and normal synovial cells a down-
ward trend with passage was found, and with rheumatoid 
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arthritis synovial cells an increase trend was found (but not 
statistically significant). Abe et al. (1970) reported an 
increased percent type III collagen synthesis during conflu-
ency for human and guinea pig skin fibroblasts. This obser-
vation was confirmed in Table 6 for human skin fibroblast but 
the opposite was true for synovial cells. The percent of 
type III collagen synthesized was decreased by GST in both 
skin fibroblasts and synovial cells in both lo~ phase and 
confluency. Also, in an experiment in which cell number was 
unchanged due to the low GST concentration (7.SuM) a decrease 
in type III collagen was also found • . Therefore, the change 
in the percent synthesis of type III collagen is not due to 
cell density changes. 
The quantitation of medium collagen, by the fluorescent 
14 
method used here, represents the accumulation of [ C]pro-
line into collagen a chains in the synovial cell medium over 
a 5 day period. The measurement of total accumulation cir-
curnvents interpretation problems with regard to the influ-
ence of pool size changes and amino acid transport defici-
encies on label incorporation which may be altered by gold 
(Finkelstein ~t al., 1977). The radioactive values repre-
sent the incorporation of [14c]proline into collagen a 
chains during a 2 day incubation and subsequent separation 
of the radioactive collagen chains by both SDS-polyacryl-
amide gel electrophoresis and carboxyrnethyl cellulose 
chromatography. The exposure of human synovial cells to 
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GST caused a decrease in the percentage of type III collagen 
synthesized (as detected by both separation techniques) and 
also in the percentage of type III collagen which accumulates 
in the medium (based on the quantitation of media collagen 
by fluorescent gel scanning techniques). In view of this, 
and the premise that the production of both type I and type 
III collagen is dependent on the same precursor pools, indi-
cates that the direct effect of gold on amino acid transport 
or pool specific activity is not responsible for the changes 
in collagen synthesis reported here. 
The biochemical mechanism by which gold compounds alter 
proliferation and collagen synthesis in synovial cells can 
only be postulated from these experiments. The cell popula-
tion generated by this culture technique is heterogeneous 
(Marsh et al., 1974, Smith, 1971, Castor, 1970) so that the 
dose-dependent effect of GST on proliferation and, therefore, 
also on collagen synthesis could be due to a selectivity for 
certain cell populations. The alteration in collagen types 
observed here could be due to direct stimulation of the syn-
thesis of type I collagen, but we cannot rule out the pos-
sible inhibition of intracellular degradation (Bienkwski et 
al., 1978). Granulocyte collagenase has been shown to pre-
ferentially degrade type I as compared to type II! collagen 
(Horowitz et al .. , 1977). Therefore, intracellular inhibition 
of a similar enzyme may result in the secretion of increased 
amounts of type I collagen. 
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A pannus can be considered a form of granulation tissue. 
Gay et al. (1978) demonstrated by irnmunofluorescence that 
type III collagen is the early collagen laid down in granu-
lation tissue followed by type I collagen. In contrast, the 
predominant collagen type in normal scar is type I collagen 
(Bailey et al., 1973, 1975). A pannus responds to inflama-
tion by generating granulation tissue, and further maturation 
results in the formation of scar tissue. Thus, it is con-
ceivable that the alteration of the composition of the syno-
vial matrix is related to or dictates the functional nature 
of the synovium in rheumatoid arthritis. Recent preliminary 
experiments by Dayer (personal communication) indicate that 
a blood mononuclear cell factor may stimulate proline incor-
poration into collagen, with the preferential stimulation of 
a protein tentatively identified as type III procollagen. 
Parrott (manuscript in preparation) found an increaase in the 
percentage of type III collagen synthesized by cultured 
synovial cells after mononuclear cell factor stimulation. 
The data reported here estali.lish that GST has a direct 
effect on synovial cell proliferation, and on the amount and 
nature (genetic composition) of the extracellular matrix 
they produce. This shift in synthesis or accumulation of 
type I collagen over type III collagen may represent a switch 
from a proliferative granulation tissue to end stage scar 
tissue. This forced maturation may in fact be responsible 
for aborting the progressive proliferative component of the 
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rheumatoid arthritis lesion, and may represent one of the im-
portant mechanisms responsible for the therapeutic efficacy 
of gold therapy in the treatment of rheumatoid arthritis . 
Ugai et al. (1979) reported in vitro aurosome formation 
in monocytes at doses similar to those used here to form auro-
somes. However, biochemical changes in cultured synovial 
cells were found below the dose for vacuole (i.e., aurosome) 
formation. GST-induced vacuoles appeared to be irreversible 
(present after subculturing and for a month without GST in 
the medium) and biochemical recovery and elimination of gold 
(Figs. 6, 8 and 9; Tables 4 and 5) was only partial at doses 
that would cause vacuole formation. Patients withdrawn from 
gold therapy usually have a relapse or reactivation of RA 
after several months (Freyberg, 1972). Gold does decrease in 
the synovial tissue after patients are withdrawn from chryso-
therapy but is still present years later, as measured by atom-
ic absorption spectrometry (Grahme et al., 1974) and as 
found by EM (Fig. 4) and X-ray probe analysis (Ghadially et 
al., 1978). Vernon Roberts et al. (1976) using neutron ac-
tivation analyzed the localization of GST in the synovium. 
During chrysotherapy gold was abundant in synovial lining 
cells. Twenty-three years after stopping chrysotherapy gold 
was found in the subsynovial connective tissue. 
The presence of aurosomes or the presence of gold in 
tissues does not imply a level of pharmacological activity 
compatible with clinical benefit. The presence of gold in 
the cell layer after removal of GST from the medium for 4-14 
103 
days (Table 4) was significantly correlated (r =0.57) with 
biochemical changes (Table 5) but not to the degree observed 
when GST was present in the medium (r> 0.9) (Fig. 7-12). 
Thus, the gold-induced suppression in the percentage of type 
III collagen synthesized and cell proliferation return after 
removal of GST from the medium at low (10 uM) but not high 
(lOOuM) GST. 
The GST induced morphological change of the synovial 
cells in culture has a direct correlation to the morphologi-
cal change in patients' synovial cells due to chrysotherapy. 
This lends credence to the experimental model as one in 
which there is a similar processing of gold in the cell cul-
tures as in the rheumatoid joint. The biochemical effects 
of inhibition of proliferation and shift in collagen metabo-
lism to the formation of a matrix not conducive for expansion 
may be a mechanism by which gold causes remission of RA. 
The means by which these biochemical alterations occur can 
only be speculated. 
Steroids are known to bind to a cytoplasm receptor. The 
drug-receptor is modified to an "active complex"and enters 
the nucleus. Gold is internalized by cells, highly protein 
bound, effects DNA replication and gene expression. It is 
unlikely that the sequestered gold in the aurosomes can have 
these effects on the nucleus. Thus, the processing of gold 
in the aurosomes may be a means of forming an "active com-
plex" similar to the "active complex" with steroids. 
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Another means by which these biochemical effects of gold 
on synovial cells may occur is by blocking or denaturing 
necessary factors for cell proliferation and metabolism. 
Lastly, the biochemical effects of gold have striking 
similarities to the biochemical changes due to aging. Gold 
decreases the solubility of the collagen matrix by increas-
ing cross-linkages of collagen (Adam et al., 1965 and 1968). 
With age, there is an increase in collagen crosslinkages 
(Bailey and Shimokomaki, 1971; Davison and Patel, 1975). 
Gold decreases the relative percent of collagen synthesized 
by cells in culture. With age, there is a decrease in the 
relative percentage of collagen synthesized in animal tis-
sues and cells in culture (Newman and Lagner, 1975; Paz and 
Gallop, 1975). An age dependent shift from a type III col-
lagen predominance to a type I collagen predominance was 
found from fetal to adult skin (Epstein, 1974). GST causes 
a dose-dependent increase in type I collagen. Nontransforrned 
cells in culture have an aging process in which proliferation 
slows down and stops after a finite number of doublings. An 
increase in cell size and DNA content per cell has also been 
found by aging cells in culture (Greenberg et al., 1977; Pee, 
1970; Cristofalo et al., 1969). GST has an antiprolifera-
tive effect in which there is an increase in cell size and 
an increase in DNA content per cell. Therefore, a quicker 
maturation of the pannus granulation tissue is a means by 
which expansion of the hyperplastic synovial cells into oth-
er connective tissue components of the joint can be inhibited, 
and may be an explanation of the efficacy of gold in rheuma-
toid arthritis. 
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VI. CONCLUSION 
Gold sodium thiomalate (GST) causes biochemical and mor-
phological changes in cultured synovial cells at pharmaco-
logically relevant concentrations (10-lOOuM) which may be re-
lated to the efficacy of gold treatments to rheumatoid ar-
thritis patients. 
1. GST causes an analogous morphological change, auro-
somes, in cultured human synovial cells as iri. the synovial 
tissue of patients. Hence, processing of gold in vivo and 
in vitro are similar. 
2. Clinically, GST prevents the hyperplasia of the syn-
ovial cells in joints of patients with RA and inhibits cell 
division in cultured human synovial cells. The inhibition 
is reversible at low gold concentration (lOuM) but not at 
high gold concentration (lOOuM) in culture. 
3. GST alters the synthesis of extracellular matrix 
proteins. The shift in the synovial cell synthesis from 
collagen to noncollagen protein and from a type III colla-
gen (new, repair) to a type I collagen (end stage, scar) 
would cause the formation of an unfavorable matrix scaffold 
for pannus expansion. The recovery of the cell to synthe-
size type III collagen was found when GST (lOuM) was removed 
from the medium. 
Therefore, a mechanism of action of gold in rheumatoid 
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arthritis can be a direct effect on synovial cells. The gold 
induced alterations in extracellular matrix formation and 
the gold induced anti-proliferation of the synovial cells may 
work synergistically to halt the pannus. The clinical bene-
fits obtained from gold therapy, in a complex disase like 
rheumatoid arthritis, lie in a specturrn of mechanisms working 
on a variety of receptors and cells in concert. The direct 
effect of GST on synovial cells could be instrumental in pre-
venting irreversible joint damage. 
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VI I. .-\ppendix 
A. Cell lines used i n expe riment s . 
Patient Age Date of Area of 
Cell Line Initials Sex (y rs ) Biopsy BioESV Diagnosis 
RA-l 7S A.T. M 69 9/ 15/ 78 L . hip RA 
s y noviurn 
RA-l4S A.P. F 60 9/ 20 / 78 L.hip RA 
s y noviurn 
RA-18S C.P. F 26 9/ 17/ 78 L . wrist RA 
s y noviurn 
RA-19S A.P. F 60 9/ 22/ 78 L . hip RA 
synoviurn 
RA-16S C.M. F 53 9/ 13/ 78 R. knee RA 
synoviurn 
RA-21S L.N. F 54 8/ 30 / 78 R.hip RA 
synoviurn 
RA-13S E.H. M 66 11/ 28 / 77 R.knee RA 
s y noviurn 
RA-15S L.N. F 54 8/ 30/7 8 R.knee RA 
synoviurn 
RA-23 J .R. F 9/5 / 79 L.knee RA 
synoviurn 
RA-15 J . F. M 62 8/ 29 / 79 L.hip RA 
synoviurn 
RA-16 O.B. F 66 10 / 2/ 79 R.knee RA 
synoviurn 
RA-26 F.B. F 74 12/ 12/ 79 R.knee RA 
synoviurn 
RA-25 G.H. F 12 / 11/ 79 R.knee RA 
synoviurn 
RA-27 A.B. F 71 1/ 15/ 80 R.knee RA 
synoviurn 
RA-30 G.D. F 53 1/ 30 / 80 knee RA 
synoviurn 
NS-17 G.-C. M 31 9 / 4/ 79 R.knee Normal 
synoviurn 
OA-16 v.s. F 59 8/ 28/79 R. hip OA 
synoviurn 
PY-0 F 90 1 2/ 10 / 79 skin Normal 
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